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CHAPTER 1
INTRODUCTION
Chronic pain is a leading cause of suffering, disability, and high health care
costs. Patients with chronic pain have elevated health care utilization at primary care
settings, tertiary care settings, and emergency departments. Furthermore, those
patients with greater pain-related disability use even more health care services (Blyth,
March, Brnabic, & Cousins, 2004). Becker et al. (1997) found that chronic pain patients
are five times more likely to use health care services than those without chronic pain.
One study examined the economic impact of chronic non-cancer pain in the workplace
and found that each employer lost an average of $2.1 million per year because of
absences, medical, and pharmacy costs (Pizzi et al., 2005).
Although many patients with chronic pain report taking a variety of medications,
traditional medical interventions often provide limited benefit. Consequently, there has
been growing interest in the development and testing of psychological interventions for
people with chronic pain (Gatchel et al., 2007). Interventions that teach people to
manage their pain using cognitive and behavioral techniques have the most empirical
support (Compas, Haaga, Keefe, Leitenberg, & Williams, 1998). For example, pain
coping skills training is a comprehensive, empirically-supported program that includes
progressive muscle relaxation, distraction, applied relaxation, increasing pleasant
activities, problem-solving, activity-rest cycling, and cognitive restructuring (Keefe,
Caldwell, Williams, & Gil, 1990). Morley, Eccleston, and Williams (1999) determined that
compared with wait-list controls, cognitive-behavioral therapy (CBT) led to better
outcomes on all dimensions measured, with a median effect size of 0.50. There is also
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evidence that suggests that cognitive-behavioral treatments work for a range of pain
disorders. One study compared patients with fibromyalgia and chronic low back pain in
a cognitive behavioral treatment and found that both patient groups reported a
significant improvement in self-efficacy, pain, distress, disability, and depression
symptoms (Wells-Federman, Arnstein, & Caudill-Slosberg, 2003).
Not all of the studies examining cognitive-behavioral techniques have found such
positive results, however. A review of an array of psychosocial interventions, but
primarily cognitive behavioral approaches, for patients with arthritis found a much lower
effect size of 0.18 in favor of psychological interventions (Dixon, Keefe, Scipio, Perri, &
Abernathy, 2007). Also, when comparing cognitive-behavioral treatment with a wait list
control, Basler and Rehfisch (1990) found improvements on pain immediately following
treatment, yet at 6-month follow-up, effects were no longer significant. Furthermore, it
appears that only a subset of patients actually improves (Dixon, Keefe, Scipio, Perri, &
Abernethy, 2007). The Basler and Rehfisch (1990) study found that the only patients
with improved pain at the 6-month follow-up were those participants who were most
adherent to the treatment. Upon studying the effects of various CBT and/or exercise
interventions for patients with fibromyalgia, Turk (2004) concluded that only about onethird of patients benefit from the treatment.
Even though cognitive-behavioral treatments are the standard treatment for
chronic pain, the overall effects are variable and often limited. One possible explanation
is that there are different types of pain disorders. Chronic pain can be a symptom of a
specific disease in the peripheral tissues (e.g. rheumatoid arthritis, inflammatory bowel
disease, multiple sclerosis, cancer), and such patients need to learn to cope with this
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disease, its medical treatment, and their symptoms.

Improvement through

psychological interventions may be limited, and cure is not likely. There are, however,
many examples of chronic pain that lack clear, identifiable peripheral causes. Patients
with these types of chronic pain have been labeled as having functional disorders,
medically unexplained symptoms, somatoform disorders, somatization, and so on, and
include diagnoses such as myofascial pain, fibromyalgia (FM), irritable bowel syndrome
(IBS), chronic low back pain (CLBP), temporomandibular disorder (TMD), migraine
headache, tension-type headache. Such patients likely have different treatment needs
than those whose pain is largely peripheral in origin. Also, there are similarities across
these diagnoses (Yunus, 2007), and the presence of elevated stressful life events,
elevated rates of emotional disorders, and impaired emotion regulation appears to
contribute to the development and/or maintenance of these types of chronic pain
problems.
Stressful Life Events
One potential contributor to the limited efficacy of standard cognitive-behavioral
pain management techniques may be the presence of unresolved life stressors, such as
childhood and adult victimization, serious relationship conflict, shame or guilt-ridden
actions, or tragic losses. For example, childhood abuse has been associated with many
health consequences in adulthood. Walker and colleagues found that women with a
history of sexual abuse had more functional disability, more physical symptoms, more
medical diagnoses, more emergency room visits, and greater health care costs than
those without a trauma history (Walker et al., 1999; Walker et al., 1999). Hulme (2000)
described similar consequences in women from a large primary care clinic; those who
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had childhood sexual abuse reported twice the physical symptoms, more primary care
visits, greater medical charges, and twice the amount of major lifetime surgeries
compared with patients without childhood abuse.
People with a history of childhood sexual abuse are much more likely to report
chronic pain than people without a sexual abuse history (Finestone et al., 2000). One
group of researchers distinguished between childhood abuse, adult abuse, and
repeated abuse, and found that all three types of abuse were associated with chronic
pain. However, long-term abuse was associated with a greater level of pain than those
with reports of childhood and adult abuse alone (Green, Flowe-Valencia, Rosenblum, &
Tait, 2001). Similarly, when researchers compared a sample with childhood abuse to a
sample with adult domestic violence, both abuse groups reported more pain symptoms
than a control group, yet there were no differences in reported pain between the two
abuse groups (Kendall-Tackett, Marshall, & Ness, 2003). With the exception of longterm abuse, it does not seem that one type of abuse in either childhood or adulthood is
more predictive of chronic pain than another type of abuse.
Additionally, these stressful life events often occur at greater rates in patients
who develop the somatoform pain disorders than those who have pain related to
disease. For example, patients with FM had a much higher prevalence of childhood and
adult victimization than patients with rheumatoid arthritis (Walker et al., 1997). Similarly,
patients with IBS also had elevated rates of early life stressors, including sexual and
physical abuse, neglect, and loss of primary caregiver in childhood; and rape in
adulthood. Furthermore these stressful experiences have been linked with the onset
and exacerbation of IBS symptoms (Jarcho & Mayer, 2007). Comparing IBS patients to
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patients who have inflammatory bowel disease (a condition with a clear peripheral—
autoimmune--etiology) reveals a significantly greater level of physical and sexual abuse
in patients with IBS (Ali et al., 2000). In a study of the progression of acute neck and
back pain to chronic pain, greater exposure to past traumatic life events and depressed
mood were predictive of chronicity (Casey, Greenberg, Nicassio, Harpin, & Hubbard,
2008). These authors also found that more cumulative traumatic events, negative pain
beliefs (e.g., that pain may be permanent), and greater depression in a new pain
episode was related to increased severity of pain and disability.
The prior studies used clinical samples, and the help-seeking behavior of clinical
patients may result in overestimates of traumatic events in these patients. Several
epidemiological studies, however, have supported the notion that stressful life events
are associated with chronic pain (Goodwin, Hoven, Murison, & Hotopf, 2003; Linton,
2002; McBeth, Macfarlane, Benjamin, Morris, & Silman, 1999). As part of the National
Comorbidity Survey, Sachs-Ericsson, Kendall-Tackett, and Hernandez (2007) examined
the relationship between childhood abuse and chronic pain in a large community
sample. The presence of childhood abuse predicted chronic pain, and the relationship
between the abuse and chronic pain was not mediated by depression. This study
confirms that the relationship between abuse and chronic pain is not dependent on
being in treatment and recruited from treatment sites.
Emotional Disorders
Given the elevated stressful life events reported in chronic pain, one should also
find elevated rates of posttraumatic stress disorder (PTSD); indeed, this is the case.
Many studies document the comorbidity of chronic pain and PTSD. Patients with
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fibromyalgia and irritable bowel syndrome have rates of PTSD up to 37% (Amir et al.,
1997; Dobie et al., 2004), and many additional patients demonstrate subclinical
symptoms of PTSD (Sherman, Turk, & Okifuji, 2000). Interestingly, the rates of chronic
pain in people with a primary diagnosis of PTSD are even higher.

Out of 129

consecutive military veterans with PTSD, 80% reported chronic pain (Beckham et al.,
1997); this suggests that psychological trauma can precede, and presumably elicit,
chronic pain.
In addition to PTSD, other emotional disorders are also elevated in patients with
chronic pain, including mood, anxiety, substance abuse, and personality disorders
(Twillman, 2007; Weisberg & Boatwright, 2007). In a review of epidemiological data,
Twillman (2007) found that mood disorders (major depression and dysthymia) and
anxiety disorders (PTSD, generalized anxiety disorder, panic disorder, social phobia)
were common in patients with chronic pain. In one study, 68% of patients with chronic
pain met criteria for at least one Axis I disorder, whereas only 8% of the control
participants met criteria (Conrad et al., 2007). As would be expected with chronic pain,
somatoform disorders were most commonly diagnosed (60% vs. 0%); yet, mood
disorders (45% vs. 3%), anxiety disorders (23% vs. 1%), substance disorders (19% vs.
2%), and personality disorders (41% vs. 7%) were also substantially elevated.
An

examination

of

the

comorbidity

between

mood,

anxiety,

alcohol

abuse/dependence, and chronic neck or back pain in the worldwide mental health
surveys revealed that all three disorder categories were more common among people
with pain than those without pain.

Mood and anxiety disorders had a stronger

association with chronic pain than did alcohol abuse/dependence. Of the anxiety
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disorders, generalized anxiety disorder and PTSD showed the strongest association
(Demyttenaere et al., 2007). Using the same sample, Scott and colleagues (2007) found
that although depression and anxiety were both independently associated with a range
of physical conditions, comorbid depression and anxiety had the strongest association
with several physical conditions including chronic headache, back and neck problems,
and multiple pains. Furthermore, even though the prevalence of mental and physical
disorders may differ among ethnic groups, the associations between chronic pain and
emotional disorders were virtually identical across different ethnicities (Scott, McGee,
Schaaf, & Baxter, 2008). The evidence clearly supports the argument that a variety of
emotional disorders are elevated in people with chronic pain, compared with healthy
controls. However, the presence of an emotional disorder alone does not seem like a
sufficient explanation for chronic pain, especially because the direction of the
relationship between chronic pain and emotional disorders is unclear, and emotional
disorders may reflect underlying mechanisms that may be responsible for both the
emotional disorder and the pain.
Emotion Regulation
Elevated levels of stressful life events and emotional disorders are not the only
contributors to the development of chronic pain. Rather, it appears that stressful life
events may give rise to impaired emotion regulation, which may then lead to emotional
disorders. Although definitions and theoretical views of emotion regulation are still
evolving (Rottenberg & Gross, 2007), emotional regulation appears to include at least
four processes. The first, emotional awareness, involves attending to one’s feelings,
differentiating feelings from physical states, and labeling one’s feelings. The second

8
process, emotional expression, involves variations in the degree to which emotions are
suppressed or expressed, including their imaginal, verbal, and behavioral expression. A
third process can be labeled emotional management, and refers to being able to temper
or elicit various emotions as needed for goal attainment. The fourth emotion regulation
process, emotional integration, refers to the emotion-facilitated alteration or relearning
of maladaptive beliefs and cognitions, with a consequent reduction in negative emotion.
This occurs by learning about one’s feelings, reflecting on an event’s meaning, and
either adapting the experience into one’s current thinking, or altering one’s beliefs to
accommodate the experience. This dissertation will focus on the first two processes of
emotion regulation: emotional awareness and emotional expression.
Although there is little direct evidence linking emotion inhibition and increased
pain, substantial research suggests that when people avoid or inhibit negative emotions,
memories, and thoughts stemming from stressful experiences, the central and
autonomic nervous systems can trigger or exacerbate pain. For example, patients with
fibromyalgia have greater levels of emotion suppression and alexithymia than controls
(Brosschot & Aarsse, 2001), and more than half of fibromyalgia patients report difficulty
expressing emotions, which is much greater than patients with rheumatoid arthritis or
healthy controls (Dailey, Bishop, Russell, & Fletcher, 1990). Furthermore, in response to
an induced negative mood and an interpersonal stressor, fibromyalgia patients
responded with greater pain than patients with osteoarthritis—a peripheral diseaserelated pain disorder (Davis, Zautra, & Reich, 2000).
Alexithymia was originally described in people with psychosomatic disorders and
is an example of the first emotion regulation process; it encompasses difficulty
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identifying feelings, difficulty describing feelings, externally oriented thinking, and a
limited imaginal capacity (Nemiah, Freyberger, & Sifneos, 1976; Taylor, Bagby, &
Parker, 1997). Elevated levels of alexithymia have been found in a wide range of
medical conditions including chronic pain and emotional disorders such as PTSD. The
view that alexithymia is a risk factor for medical and psychiatric problems that are
influenced by disordered affect regulation is growing in empirical support (Taylor et al.,
1997), and recent studies have begun to link alexithymia to pain.
Lumley, Neely, and Burger (2007) described potential pathways by which
alexithymia may influence chronic pain. One way is by contributing to symptom
reporting. People with alexithymia may be more likely to describe emotional arousal in
somatic terms or to report only the physiological sensations of emotion rather than the
emotional label. Also, the tendency to notice and be concerned about physical
sensations—somatosensory amplification—may be increased in alexithymic individuals.
Many research studies have found that people with alexithymia report more somatic
symptoms, including pain. One review of 18 samples reported a mean correlation of r =
.23 between alexithymia and somatic symptoms (De Gucht & Heiser, 2003).
Furthermore, alexithymia is usually greater in people with chronic pain than controls
without pain (Ak et al., 2004; Burba et al., 2006; Celikel & Saatcioglu, 2006). For
example, alexithymia was associated with nonspecific shoulder pain severity (Miranda
et al., 2005) and fibromyalgia (Sayar et al., 2004). In addition, alexithymia is positively
associated with pain severity among people with chronic pain. In a large sample of
Finish workers with temporomandibular disorder, alexithymia was positively correlated
with head, neck, and tooth pain (Ahlberg et al., 2004). In a prospective study of patients
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with temporomandibular disorder, Glaros and Lumley (2005) found that not only was
alexithymia positively related to pain severity during daily activities even after controlling
for depressed mood, but also that the pain severity was unrelated to tissue damage.
Alexithymia is also associated with greater affective pain in patients with chronic
myofascial pain after controlling for catastrophizing and self-efficacy (Lumley, Smith, &
Longo, 2002). It appears that alexithymia is related to increased symptom severity
regardless of tissue damage, which may help explain the similar rates of alexithymia in
different patient groups.
The second process of emotion regulation that will be studied in this dissertation
relates to expression and inhibition of emotions. One line of research examines the
common regulatory processes of emotion suppression and positive reappraisal. Studies
examining the effect of suppression on emotional experience have found that although
suppression is effective at decreasing the outward expression of negative emotions, it
actually increases physiological arousal and exacerbates the experience of emotion,
compared with not suppressing (Gross & Levinson, 1997; Gross, 1998). These findings
are consistent with research documenting the paradoxical nature of thought
suppression, which shows that when participants are instructed to suppress a thought
there is actually increased thought on that topic (Gold & Wegner, 1995; Wegner
Schneider, Carter, & White, 1987). In addition to affecting emotional experience,
suppression also increases physiological responding (Gross, 2001). For example,
participants instructed to suppress emotions of disgust experienced greater constriction
of blood vessels. These effects have also been replicated for amusement and sadness
but do not occur when participants are instructed to express during a neutral stimulus or
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when instructed to reappraise. Thus, Gross (2001) concludes that the act of inhibiting
the expression of emotions impacts physiological factors.
The use of emotional suppression as a regulation strategy has been linked to the
development and maintenance of psychopathology (Amstadter, 2008; Gross & John,
1998). For example, in a sample of Vietnam veterans, those with PTSD used more
suppression of both negative and positive emotions than those without a PTSD
diagnosis (Roemer, Litz, Orsillo, & Wagner, 2001). More importantly, greater use of
suppression was related to greater severity of PTSD symptoms. Therefore, using
suppression as an emotion regulation strategy leads to increased negative emotions
and decreased positive emotions in people with PTSD.
A few studies have researched the effects that anger suppression has on pain.
Some of the studies have demonstrated the negative effects of suppression on
experimental pain in healthy controls. Quartana, Yoon, and Burns (2007) found that
participants in an emotion suppression condition experienced greater pain on a coldpressor test during anger provocation than the control condition. These researchers
also found support for a paradoxical process by which suppressing anger actually
increases cognitive accessibility of anger. Another study by Quartana and Burns (2007)
concluded that anger suppression may lead to increased pain because participants in
the anger suppression condition rated the anger specific dimensions of pain higher than
the control condition. Recently, this research has been replicated in patients with
chronic low back pain. Patients were harassed during a computer maze task and were
randomized to either a suppression or no suppression group. Burns and colleagues
(2008) found that patients in the anger suppression group had significantly more pain
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and pain behaviors than the non-suppression group at a subsequent time while
completing a task designed to mimic everyday activities. Furthermore, degree of anger
and not anxiety or sadness accounted for the differences between the two groups.
Even though there is not much research examining the direct effects of avoiding
emotions on chronic pain, there is a line of research demonstrating the detrimental
effects of experiential avoidance. Experiential avoidance is the attempt to escape or
avoid private experiences, typically thoughts, feelings, memories (Hayes & Wilson,
1993). In the coping literature, there are two methods of avoidance coping that have
been linked to negative outcomes. Avoidant coping and emotion focused coping, which
consists of many items that measure avoidance, predict poor clinical outcomes in a
variety of mental health problems (DeGenova, Patton, Jurich, & MacDermid, 1994;
Leitenberg, Greenwald, & Cado, 1992). Hayes and colleagues argue that experiential
avoidance can actually account for the development and maintenance of many
psychological disorders, including substance disorders, obsessive compulsive disorder,
panic disorder with agoraphobia, and borderline personality disorder as well as the
negative effects of childhood sexual abuse (Hayes, Wilson, Gifford, Follette, & Strosahl,
1996).
The research on experiential avoidance is consistent with the PTSD literature, a
diagnosis that is highly comorbid with some chronic pain disorders, and that appears to
result directly from experiential avoidance of affectively charged memories. Avoidance
of stimuli associated with the trauma, re-experiencing an element of the trauma, and
increased sympathetic arousal are criteria of the PTSD diagnosis according to the
Diagnostic and Statistical Manual, IV-TR (American Psychiatric Association, 2000). The
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paradoxical effects of thought and emotion suppression noted above may help explain
the relationship among these three criteria of PTSD. The patient avoids aspects of the
trauma because they are upsetting and, therefore, the patient is actually more likely to
re-experience thoughts, feelings, or memories leading to more sympathetic nervous
system arousal. Furthermore, among patients with PTSD, the use of avoidant coping
was related to PTSD symptoms at a 1-year follow-up after controlling for initial severity
(Krause, Kaltman, Goodman, & Dutton, 2008). Thus, the research on experiential
evidence and its similarities with PTSD suggests that emotional avoidance is an
important target for chronic pain interventions.
Addressing Unresolved Stress and Emotions
Even though the role of stress, trauma, and emotion regulation in contributing to
chronic pain has been documented, there is no validated psychological treatment that
directly targets pain patients’ unresolved stress and emotional avoidance. Lesserman
(2005) reviewed treatments for PTSD and chronic pain and concluded that there is a
need for exposure-based treatments for chronic pain patients with a PTSD diagnosis or
with a trauma history. Although not much progress has been made since this 2005
review, there are several other current interventions and techniques that provide
support for the rationale of an emotional exposure or emotional processing type of
treatment. Also available is a potentially exciting and effective psychosocial treatment
that helps patients recognize the key role of stress and emotions in their experience of
chronic pain, and this dissertation will focus on the efficacy of this latter intervention.
Written emotional disclosure, or expressive writing, a technique introduced by
Pennebaker and Beall (1986), attempts to help participants resolve stress by writing
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about their thoughts and feelings related to a traumatic event. Participants are typically
randomized to writing about stress or trauma or to a control writing condition and write
for several days. Originally, written emotional disclosure was tested in healthy
populations and found to lead to significant improvements in health and functioning
(Smyth, 1998). However, studies of the effects of writing about stress in chronic pain
populations yielded less impressive results. Published studies show written emotional
disclosure has weak effects on pain and other medical conditions (Broderick, Stone,
Smyth, & Kaell, 2004; Frisina, Borod, & Lepore, 2004; Kelley, Lumley, & Leisen, 1997;
Meads, Lyons, & Carroll, 2003; Norman, Lumley, Dooley, & Diamond, 2006). Although
many of the studies do not seem to support the use of this technique for chronic pain,
there have been two studies of written emotional disclosure in patients with fibromyalgia
that have demonstrated positive results (Broderick, Junghaenel, & Schwartz, 2005;
Gillis, Lumley, Mosley-Williams, Leisen, & Roehrs, 2006). The benefits found in patients
with fibromyalgia may be attributed to the higher levels of unresolved stress found in
this group than in patient groups with rheumatoid arthritis or headaches. It is possible
that this technique is too brief and too limited in focus to produce positive effects.
Furthermore, it requires participants to identify their key issues themselves, a skill that
may be lacking in many participants. WED could still be useful as a component of a
treatment targeting unresolved stress and emotions.
Some of the largest support for an exposure-based treatment that targets
unresolved stress and emotional avoidance stems from the literature on exposurebased treatments for anxiety disorders. The use of imaginal and in vivo exposure
without allowing the patients to avoid or escape the anxiety-provoking stimuli has shown
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significant success for treating phobias, obsessive-compulsive disorder, and PTSD
(Barlow & Lehman, 1996). Patients experience the feared and avoided stimulus—either
an object, situation, or affective memories—in a safe and predictable environment with
the support of the therapist.
With the exception of several studies of written emotional disclosure, which show
modest benefit for chronic pain, emotional-exposure based techniques have not been
applied to chronic pain patients. However, Lumley and colleagues (2008) have
developed an emotional exposure-based intervention to address the unresolved trauma
identified in some patients with chronic pain. This treatment attempts to identify avoided
experiences and encourage the patient to engage in exposure exercises so that
emotional processing and relearning occur, leading to improved pain and health.
Techniques such as education about experiential avoidance, written emotional
disclosure, imaginal and in vivo exposure, and meta-communication among others are
used to accomplish this purpose. Although this treatment is still under development and
has not been validated in a controlled trial, a preliminary report evaluating the
treatment’s efficacy for patients with fibromyalgia shows promising results (Lumley et
al., 2008). In a sample of ten patients, there were significant improvements in
unresolved stress symptoms, and marginally significant improvements in overall
fibromyalgia symptoms, emotional distress, life satisfaction, and disability. Furthermore,
reliable change indices showed that six of the 10 patients made at least moderate and
meaningful changes.
Much more research is needed on psychosocial treatments that target emotional
avoidance that might underlie pain, especially pain found in people with somatoform

16
pain disorders (those without clear, contributing organic disease). Schubiner, a
physician at Providence Hospital in Michigan, has created a 4-session group
psychosocial treatment for patients with a diverse range of chronic pain problems. He
was influenced by the work of Sarno (1998), who argued persuasively in the book, The
Mindbody Prescription, that the many musculoskeletal pain problems that lack
identifiable pathology are caused by repressed emotions. Sarno proposed that
seemingly diverse pain problems are different manifestations of what he termed
“tension myositis syndrome,” and should be treated by repudiating the medical
diagnosis for the pain and accepting the psychological cause for the pain (repressed
emotions). Schubiner has labeled the chronic pain problems in his treatment mind body
syndrome (MBS)/tension myositis syndrome (TMS). His treatment uses readings,
writing about emotions, meditation, and other techniques to help people identify,
understand, and verbalize emotions related to stressful life events or emotional conflict.
Schubiner’s treatment program, entitled, “Healing Yourself in Six Steps,” has these
components:
1. Recognizing the True Disorder (TMS): Repudiating the Physical
2. Reading about TMS Each Day
3. Writing Exercises: Write Away Your Symptoms
4. Reflecting Exercises: Mindfulness Practice for Healing
5. Reprogramming the Mind: Self-Talk and Training the Unconscious
6. Rebuilding Your Life: Moving Towards the Light
Many

of

Schubiner’s

patients

anecdotally

report

benefits

including

large

improvements in pain. One controlled study has evaluated the effects of this treatment
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compared to a wait-list control with a small sample of fibromyalgia patients (Hsu,
Schubiner, Lumley, Stracks, Clauw, & Williams, in press). At a 6-month follow-up
patients in the intervention group reported significantly lower pain severity, higher selfreported physical functioning, and higher tender-point threshold compared to the control
group. Additionally, nearly half of the patients in the intervention group had at least a
30% reduction in pain severity compared to no patients in the control group. The effect
of this treatment is still unknown outside of a randomized controlled trial with a broad
range of chronic pain patients. Furthermore, research is still needed to identify
moderators and mediators of this treatment protocol.
Predictors of Treatment Outcome
The presence of different types of chronic pain suggests that the “pain-patient
homogeneity” myth should be discarded, and instead, factors that contribute to
differential responding should be identified (Turk & Okifuji, 1998). Not all pain patients
will have stressful life events or unresolved emotional conflict that is causing or
exacerbating their pain. Furthermore, even some patients who do have unresolved
emotional issues will not respond to this intervention for various reasons, such as
varying motivation, adherence, emotional abilities, and so on. Most of the research on
evaluating predictors of treatment response has been conducted with cognitive
behavioral treatments, and few predictors of treatment success have been identified. In
a study of CBT for temporomandibular disorder, patients with greater baseline
somatization, depressive symptoms, number of pain sites, rumination, catastrophizing,
and perceived stress had greater activity interference one year after treatment;
however, none of these variables predicted change in pain (Turner, Holtzman, & Mancl,
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2007). Even though this type of emotion-focused treatment has not been systematically
evaluated, a review of the literature suggests several potential predictors of outcomes
that may be relevant for a treatment that targets unresolved stress and poor emotion
regulation, including baseline depression, stress, emotion regulation, and attitudes
toward treatment.
Alexithymia is one of the most researched emotion regulation predictors, and it
appears that alexithymia usually predicts poorer outcomes of emotion-oriented
treatments. Some studies suggest that patients who are alexithymic respond more
poorly to emotion-oriented interventions. A dissertation examining the effects of an
internet-based emotional disclosure intervention in kidney transplant patients found that
although patients who typically suppress their emotions benefitted more from
disclosure, patients who were alexithymic benefited less (Posemato, 2008). Similarly, in
a study of expressive talking in rheumatoid arthritis patients, alexithymia overall did not
moderate outcome, however, higher scores on the subscale difficulty identifying feelings
predicted increased disability in the expressive talking condition but not in the control
condition (Kelley et al., 1997). The role of alexithymia as a predictor of worse outcome
was also found in a sample of chronic pelvic pain patients (Norman et al., 2004). In this
study, greater alexithymia scores predicted increased pain in the emotional disclosure
group but not in the control.
Even though alexithymia interfered with positive results in the prior studies, there
are also examples of alexithymia predicting better outcomes. A study of emotional
disclosure with university students found that the difficulty describing feelings subscale
of alexithymia predicted improved physician illness visits, depression symptoms, and
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sleep disturbance after written disclosure, but externally oriented thinking subscale
predicted increased intrusion and hyperarousal symptoms. (Baikie, 2008). An
examination of psychological responses and recovery following bladder surgery found
that the alexithymia total score and the subscale difficulty identifying feelings predicted
better outcome following emotional disclosure about the upcoming surgery as compared
with controls (Solano, Donati, Pecci, Persichetti, & Colaci, 2003).
Several factors regarding the participants’ thoughts and behavior during
treatment have been found to predict treatment outcome. Participants who were most
adherent to a treatment protocol had the greatest reduction in pain intensity (Basler &
Hans, 1990). Treatment expectancy also has been found to predict outcome in cognitive
behavioral treatments for chronic pain. Using a sample of patients with fibromyalgia and
chronic low back pain from two randomized controlled trials, researchers found that
pretreatment expectancy significantly predicted outcome both immediately and at a 12month follow-up (Goossens, Vlaeyen, Hidding, Kole-Snijders, & Evers, 2005). In
addition to treatment expectancy, the perceived credibility of the treatment seems
important as well. In another sample with chronic low back pain, treatment credibility
was one of the strongest predictors of outcome regardless of which condition the
participants were assigned (Kole-Snijders, et al. 1999).
Preparing Patients for Treatment: Emotional Assessment
As discussed above emotion regulation involves many components. The ability to
express emotions and wishes/needs in an open manner and free from anxiety is an
important manifestation of healthy emotional functioning, and one that is of interest for
this dissertation. One method of categorizing relational emotions is to consider two
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domains

of

autonomy/independence

and

attachment/dependence.

The

autonomy/independence domain consists of the ability to say no, to disagree with
another’s

opinion,

and

to

communicate

emotions

like

anger.

The

attachment/dependence domain consists of the ability to ask for help and to
communicate gratitude and emotions such as guilt and love. Mental health is indicated
by having healthy awareness and expression of both of these needs.
Many patients, however, are not always able to identify avoided emotions nor do
they recognize the impact of not expressing these emotions on other aspects of their
lives, particularly their pain. Therefore, this dissertation will include an assessment
intervention that is meant to help patients in this regard.
The format of this behavioral assessment was partially influenced by Finn’s work
on therapeutic assessment (Finn, 1996; Finn, 2003). Finn considers assessment a
semi-structured collaborative process that includes various assessment tools and what
he has termed “assessment intervention sessions.” The goal of these sessions is to
explore hypotheses and help the client reach new understanding. Finn often uses
therapeutic assessment as a tool to help patients and therapists identify targets for
therapy, particularly in situations when there is no improvement in treatment.
Therapeutic assessment can be a useful tool to help prepare patients for
treatment so that they will have better outcomes. One way to help prepare patients for
an emotion-focused intervention such as the one that Schubiner offers, and which is the
focus of this dissertation, is by making the avoided emotional and relational stimuli more
salient. It would be ideal to help patients not only report their avoidance behavior with
respect to autonomy/independence and attachment/dependence, but also to test the
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avoidance behaviorally/experientially and then, importantly, have patients explore how
these assessment data are linked with their core issues, needs, stressors, emotions,
and pain. This emotional assessment approach is novel, but it may make patients more
open or motivated for this type of treatment.
Goals and Hypotheses
This study sought to further our understanding of emotion-focused treatments for
patients with chronic pain that target unresolved stress and avoided emotions. Although,
it has been demonstrated that patients with chronic pain have elevated stressful life
events, emotional disorders, and poor emotion regulation, particularly avoidance or
inhibition of key emotions, there is a dearth of research on treating these problems. The
current study has three main goals to address the current limitations of the research.
Evaluating treatment outcome. The first goal of the current study was to evaluate
Schubiner’s intervention by determining the effects of this intervention using a pre-test,
post-test, and 3-month follow-up design. Although a randomized, controlled trial is
considered the gold standard experimental design for determining efficacy, an initial
step in the development of interventions is to evaluate change in an uncontrolled study.
Calculating effect sizes as well as the number of people who benefit from the treatment
are significant steps in the evaluation process.
Hypothesis 1. It was hypothesized that participating in this treatment would lead
to improvements in chronic pain, pain-related disability, depression, and quality of life.
Specifically, greater than one-third of the participants were hypothesized to improve
after this intervention, which is the percentage of patients Turk found improved in a
review of CBT treatments.
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Identifying Predictors of Treatment Outcome. Given the evidence that not all
patients respond to an intervention, the second goal of this study was to identify the
factors that predict to successful outcomes in this intervention. Because this was a
single group study, I could not examine actual moderators of treatment outcome, rather
I examined several variables that may predict treatment outcome. As described above,
patients with increased emotional disorders, stressful life events, and in some cases
poor emotion regulation often have poorer treatment outcomes than pain patients
without these characteristics. Therefore, these predictors were examined in this
dissertation. Because treatment credibility and expectancy have predicted better
outcomes in cognitive behavioral treatments, these factors were studied as well.
Hypothesis 2. It was hypothesized that higher baseline levels of depression,
stressful life events, and poor emotion regulation skills would predict poorer outcomes
of treatment. In addition, higher baseline ratings of treatment credibility and expectancy
would predict better treatment outcomes than low treatment credibility and expectancy.
Novel Behavioral Assessment of Emotional Ability. The third goal of the current
study was to develop and test an innovative type of emotional assessment method, in
which the capacity to express emotions in an interpersonal context is assessed and the
explored. Half of the participants were randomized to receive the additional emotional
assessment. The goal of this assessment is to help prepare patients for treatment, and
thus, it would be important to compare the two groups on outcome measures.
Hypothesis 3. It was hypothesized that the participants randomly assigned to the
novel behavioral assessment group would have better outcomes than the participants
assigned to the standard assessment group.
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CHAPTER 2
METHOD
Participants
Participants were patients with chronic pain referred for the treatment program at
Providence Hospital/St. John’s Health System. Participants reported chronic pain for at
least 3 months duration as their primary symptom and had a pain problem in which
substantial psychological factors are believed to contribute to the pain. Thus, pain
patients included those with diagnoses of fibromyalgia (FM), irritable bowel syndrome
(IBS), chronic low back pain (CLBP), temporomandibular disorder (TMD), myofascial
pain syndrome (MPS), regional soft tissue pain syndrome (RSTPS), migraine
headache, and tension-type headache. Additional pain types (e.g., neck and shoulder,
non-cardiac chest pain) were included if no clear peripheral organic etiology was
suspected. Patients were excluded who have pain disorders that are secondary to
primary organic diseases (e.g., rheumatoid arthritis, inflammatory bowel disease,
multiple sclerosis, lupus, sickle cell, cancer). Additional criteria for exclusion were the
presence of current psychotic disorder, active suicidality or homicidality, current alcohol
or drug dependence, dementia, mental retardation, or non-literacy in English—all of
which were assessed by the evaluating physician.
Procedure
Patients referred to Schubiner’s treatment program were first screened over the
telephone by Schubiner, and if deemed appropriate for treatment, were asked to
purchase and read Sarno’s book, The Mindbody Prescription (1998). At this time,
patients were mailed a set of background clinical measures, which included several pain
and functioning measures analyzed in this study. Patients then met with Schubiner who
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completed his standard evaluation, which included a medical history and physical
examination to confirm inclusion criteria, rule out organic disease as the primary cause
of the pain, and to help patients recognize the key role of stress and emotions in their
experience of pain. Schubiner described the study to patients who signed up for his
intervention and asked them for permission to be contacted by a researcher. These
patients were contacted by one of the interviewers on the research team to schedule a
meeting at Providence Hospital. Potential participants then completed the written
informed consent document (See Appendix A), approved by the Human Investigation
Committees of both Providence Hospital and Wayne State University. Upon completion
of the informed consent, participants completed the pre-treatment assessment, the
treatment, and the post-treatment and 3-month follow-up assessment. The pretreatment assessment and the treatment occurred at Providence Hospital. Initially, the
post-treatment assessment was completed at the hospital and the 3-month follow-up
was mailed to the participants. However, to reduce the burden on participants, the posttreatment assessment was mailed to them as well. Participants were also compensated
$90 for completing both assessments. They received $50 for completing the pretreatment assessment, $30 for completing the post-treatment assessment, and $10 for
completing the 3-month follow-up.
Seventy-three patients agreed to be contacted by the research team. A total of
46 patients (63%) enrolled in the study. The remaining 37% did not participate for the
following reasons: not interested (33%), did not participate in the treatment (22%), could
not complete the baseline assessment before the start of treatment (19%), never
returned the initial call (11%), did not report pain as a primary problem (7%), unknown
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(4%). At the time of data analysis, 4 participants had not returned follow-up data yet.
Three of the participants (7%) dropped out of the study and did not provide any followup data (one participant never took the treatment and two were for unknown reasons).
Of the 39 participants who remained in the study and provided post-treatment data, 32
(82%) provided 3-month follow-up data by the time of the analysis cut-off point. The
sample averaged 51.05 years of age (SD = 15.52). The majority were women (76.1%)
and Caucasian (91.3%). One participant each was African American, Middle Eastern,
and Armenian. One participant did not identify an ethnicity.
Baseline assessment. Participants underwent a comprehensive psychosocial
assessment which included completion of the outcome measures as well as stress and
emotion regulation measures.
Experimental Emotional Assessment. Additionally, half of the participants were
randomized to a group that included a novel emotional assessment that assessed the
capacity to express emotions (Appendix B). The behavioral tests are comprised of two
dimensions: dominance/autonomy and vulnerability/attachment. After the behavioral
task, these participants then engaged in a discussion with the interviewer to explore
links between their assessment and their histories, relationships, and pain to help
prepare them for the treatment. The goal of this additional assessment was to help the
participants create further awareness that may help identify key targets for the
intervention. The behavioral assessment and the following discussion were completed
by trained clinical graduate students. These sessions were also audio-taped; however,
because this assessment is under development, these tapes will be analyzed at a future
time.
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Psychosocial Treatment. This manualized intervention for mind-body syndrome
(MBS)/tension myositis syndrome (TMS), created and provided by Howard Schubiner,
M.D., involves a medical history and evaluation followed by tailored education about the
patient’s unique pain onset and course, related to stressful life events. This is designed
to help patients recognize the key role of stress and emotions in their experience of
pain. Patients then take a 4-session class that uses readings, writing about emotions,
meditation, and other techniques to help people identify, understand, and verbalize
emotions related to stress. Patients are instructed to complete daily homework
assignments that include reading, writing, reflecting, reprogramming the mind, and
rebuilding exercises, which typically total one hour each day. Classes usually include six
to ten patients and occur once per week for four weeks at Providence Hospital. Each
class is two hours.
Post-treatment Assessment. Following completion of the treatment, participants
then completed the outcome measures again as well as measures of treatment
engagement and adherence. As mentioned above, this assessment was initially
completed in person at Providence Hospital but was later modified to be completed
through the mail to reduce patient burden.
3-month Follow Up Assessment. Participants were mailed the primary outcome
measures along with a pre-stamped, self-addressed envelope for returning the
completed measures.
Measures
There were two sets of measures in this study. At the baseline and posttreatment psychosocial assessments, participants completed a standard set of clinical
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outcome measures of adjustment: general health, pain, disability, psychological
impairment, health care utilization, and attitudes toward treatment. At the baseline
assessment only, participants also completed measures of stressful life events,
emotional disorders, and emotion regulation, which served as potential predictor
variables. Three of the outcome measures (Brief Pain Inventory, Center for
Epidemiological Studies-Depression, and Satisfaction with Life) were given to the
patients as part of routine clinical care and were completed prior to their initial medical
evaluation. These measures were classified as “pre-baseline.” The remaining measures
were classified as “baseline” when completed prior to treatment, as “post-treatment”
when completed following completion of the treatment, and as “3-month follow-up” when
completed at the 3-month follow-up assessment.
Primary Outcome Measures (Pre-baseline, Post-treatment, and Follow-up)
This dissertation assessed measures of general health, pain, disability,
psychological impairment, and relationship problems.
Pain. Pain severity and pain-related disability were assessed using the Brief Pain
Inventory (BPI; Daut, Cleeland, & Flanery, 1983). It assessed pain severity and pain
interference with a 0 to 10 scale with 10 indicating greater severity. The pain severity
items ask responders to rate their pain at the present moment in time and their worst,
least, and average pain over the past week. For this study, these items were averaged
to form a pain severity score. There are also 12 items that ask patients to rate how
much their pain interfered with the activity listed. Because of an error printing the
measure for this study, only the first 4 disability items were included (general activity,
mood, mobility, and normal work), thus, these items were averaged to produce a pain-
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related disability score. Alpha in this sample was 0.90 for the pain severity items and
0.86 for the disability items.
Depression. The Center for Epidemiological Studies Depression Scale (CES-D;
Radloff, 1977) is a 20-item scale that measures depressive symptomatology.
Participants are instructed to focus on depressed mood during the past week. This
scale can be analyzed as a continuous measure of the relative degree of depressive
symptoms, or it can be analyzed as a dichotomous measure using a cut-off score of 16,
with scores above 16 indicating symptom levels suggestive of depression. Normative
studies have found rates between 8.7% and 17.4% of women scoring above 16 on the
CES-D (Knight, Williams, Mcgee & Olaman, 1997; Myers & Weissman, 1980; Roberts &
Vernon, 1983). This measure was mailed to participants prior to the baseline
assessment. Alpha in this sample was 0.91.
Life satisfaction.

The 5-item Satisfaction with Life Scale (Diener, Emmons,

Larsen, & Griffin, 1985) was administered to measure one’s perception of general life
satisfaction. Items were rated on a 1 to 7 scale and averaged; higher scores indicate
greater global life satisfaction. Alpha in this sample was 0.85.
Secondary Outcome Measures (Baseline, Post-treatment, and Follow-up)
Affective and sensory dimensions of pain. The McGill Pain Questionnaire-Short
Form (Melzak, 1997) was used to assess sensory and affective dimensions of pain that
patients have experienced over the prior week. This 15-item self-report presents 11
sensory adjectives and 4 affective adjectives rated on a 0 (none) to 3 (severe) scale.
Discriminate validity is good with the demonstrated ability to distinguish various types of
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pain, particularly acute versus chronic pain. Alpha in this sample was 0.86 for the
sensory subscale and 0.78 for the affective subscale.
Chronic pain acceptance. The Chronic Pain Acceptance Questionnaire (CPAQ;
McCracken, Vowles, & Eccleston, 2004) is a 20-item measure of pain-related
acceptance. It has 2 subscales: Activity Engagement and Pain Willingness. The items
are rated on a 0 (never true) to 6 (always true) scale with higher scores indicating
greater acceptance. The CPAQ has good internal consistency, test-retest reliability, and
validity (McCracken & Eccleston, 2005; McCracken et al., 2004, 2005). In this study, the
total score was analyzed. Alpha in this sample was 0.88.
Stress cognitions and symptoms. The Impact of Events Scale-Revised (Weiss &
Marmar, 1997) is a 22-item scale that assesses symptoms of cognitive intrusions,
cognitive avoidance, and hyperarousal during the past week with respect to a specific
stressful event. In this study, participants were instructed to identify the single most
stressful event or experience that they have had and that continues to bother them, and
to answer questions with respect to that event. The items are ranked on a 5-point scale
(0 = not at all and 4 = extremely). The scale has excellent internal consistency reliability
(alpha = .96) and was found to correlate highly (r = .84) with the PTSD Checklist, a
measure designed to assess DSM-IV symptoms of PTSD (Creamer, Bell, & Failla,
2003). Participants identified a stressor upon completion of the baseline assessment
and wrote it on the questionnaire and were instructed to complete the questionnaire with
respect to that stressor at the post-treatment assessment. Alpha in this sample was
0.93.
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General Emotional Distress. The Brief Symptom Inventory (BSI; Deragotis, 1975)
was used to assess general emotional distress. The measures consists of 53 items
rated on a 0 (not at all) to 5 (extremely) scale indicating level of distress about each
symptom over the past 7 days. There are 3 global indices that broadly assess emotional
distress (Global Severity Index (GSI), Positive Symptom Distress Index, and Positive
Symptom Total) in addition to 9 subscales (Somatization, Obsession-Compulsion,
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic anxiety, Paranoid
ideation and Psychoticism) that measure more specific symptoms of distress. The GSI
is the most broadly used global score and has good test-retest reliability and validity
(Conoley & Kramer, 1989; Deragotis, 1993; Derogatis, Rickels, & Rock, 1976). Only the
GSI was analyzed for this study. Alpha in this sample was 0.93.
Predictor Measures (Baseline only)
Stressful Life Events. The Life Stressor Checklist-Revised (Wolfe, Kimerling, &
Brown, 1993; Wolfe, Kimerling, Brown, Chresman & Levin, 1996) contains 30 life stress
items that meet DSM-IV-TR criteria for PTSD along with other stressful life experiences.
The PTSD qualifying items also ask participants about their perception of harm or
lethality, the intensity of their emotional reaction, and how much the event has affected
them during the past year on a 1 to 5 scale. The non-PTSD questions only ask about
the stressful experience’s effect during the past year. The Life Stressor ChecklistRevised has demonstrated good criterion-related validity for PTSD in women and has
performed adequately in populations with comorbid substance abuse and other
psychological disorders (McHugo et al. 2005; Wolfe & Kimmerling, 1997). The number
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of stressful life events was summed and analyzed in this study along with the average
level of distress associated with the stressful life events.
Alexithymia.

The Toronto Alexithymia Scale-20 (TAS-20; Bagby, Parker, &

Taylor, 1994) assesses not only the global alexithymia construct, but also three facets
of alexithymia: difficulty identifying feelings, difficulty describing feelings, and externally
oriented thinking. The scale has good reliability and is the most extensively validated
measure of alexithymia (Bagby, Taylor, & Parker, 1994). Because the three subscales
of the TAS-20 appear to have differential validity and tap different aspects of emotional
regulation, the subscales were analyzed as well as the total score. Alpha in this sample
was 0.86 for the total score, 0.81 for the difficulty identifying feelings subscale, 0.78 for
the difficulty describing feelings subscale, and 0.56 for the externally oriented thinking
subscale.
Emotional awareness. The 10-item version of the Levels of Emotional Awareness
Scale (LEAS; Lane et al., 1990) was also administered. This measure presents short,
emotionally provocative vignettes, and participants are asked to write on a sheet of
paper how they would feel as well as how the other person in the vignette would feel. A
scoring manual was used to rate these responses for the sophistication or complexity of
their emotional language.

This measure has good internal consistency, very high

interrater reliability, and predicts a range of criteria, including ability to identify emotions
in faces, hemispheric dominance, and anterior cingulate gyrus activity (Lane et al.,
1995, 1996, 1998). Trained undergraduate students rated the responses using the
scoring manual.
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Emotional expression conflict.

The 28-item Ambivalence Over Emotional

Expression Questionnaire (AEQ; King & Emmons, 1990) was used to assess the
experience of both desiring to express emotion and the conscious inhibition of doing so.
The AEQ has high reliability and predicts negative mood and physical symptoms better
than measures of the frequency of expressing emotion (King & Emmons, 1990). Alpha
in this sample was 0.81.
Treatment Attitudes Survey. This 10-item survey assessed participants’ thoughts
regarding the rationale of the intervention. Participants rated their beliefs on a 5-point
scale to questions like: “How much do you think that stressful life events or trauma
cased your pain problem?”, “How much do you think that the source of your pain is in
your mind?”, and “How much do you think that your mind can eliminate the pain?” Alpha
in this sample was 0.84.
In addition, because baseline levels of some of the outcome measures may
predict who benefits from this treatment, several outcome measures were also explored
as predictor variables. Specifically, baseline levels of depression (CES-D) and
emotional distress (BSI) were tested as predictors.
Data Analysis
The data was checked for accuracy and frequency distributions of all items and
scored variables were examined for outlier variables. Internal consistency (alpha) was
assessed for all scales.
Hypothesis 1
Several analyses were conducted to determine the effects of the intervention on
chronic pain, pain-related disability, depression, and quality of life. First, a series of
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paired-sample t-tests were used to determine the statistical significance of changes
from baseline to post-treatment and baseline to the 3-month follow-up. Second, effect
sizes were calculated to determine the magnitude of change at both of these time
points. The effect sizes were calculated using Cohen’s d (post-treatment mean –
baseline mean/baseline standard deviation). Values of 0.2, 0.5, and 0.8 are considered
small, medium, and large respectively. Finally, individual patient outcomes were
examined using the reliable change index (RCI), which indicates how much change
occurred while accounting for measurement error across time. It is a ratio of the
individual patient’s change score (follow-up value minus baseline value) to the sample’s
standard error of the difference between the score. The formula for the standard error of
measurement includes the baseline standard deviation and reliability (Cronbach’s
alpha) of the measure. A separate RCI was calculated for both the post-treatment and
the 3-month follow-up. Two cut-offs were used to determine the magnitude of individual
change: 1.96 (p < .05), which represents a large effect but is very conservative, and
0.50, which represents a moderate effect.
Hypothesis 2
To identify predictors of treatment outcome, a series of partial correlations were
used. Each predictor was correlated separately with each outcome measure change
score; that is the difference between baseline and outcome (post minus pre values).
The correlations were statistically adjusted for patients’ age and gender, because these
variables were related to one or more of the predictors.
Hypothesis 3
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To determine the effects of the novel emotion communication assessment on
outcomes, separate ANCOVAs examined whether the participants who received the
therapeutic assessment did better on outcome measures than those who did not
receive it. Group was used as the independent variable, and the change scores at posttreatment and 3-months were used as the dependent variable. These analyses covaried
age, which was marginally significant different between the two groups at baseline.

35
Chapter 3
Results
Estimating changes in outcome
A set of paired-sample t-tests were conducted to evaluate the impact of the
intervention on the participants’ pain, pain-related disability, pain acceptance,
depression, general emotional functioning, and quality of life at both post-treatment and
at the 3-month follow-up. In addition effect sizes were calculated using Cohen’s d to
determine the magnitude of change on the outcome measures. The complete results of
these t-tests and effect sizes are presented in Table 1.
These analyses indicated that there were statistically significant improvements
for the sample overall, for all measures at both post-treatment and at 3-month follow-up.
Participants reported improved pain scores on multiple dimensions. First, they rated
their pain on a 1-10 scale (BPI) significantly lower at both time points compared with
baseline. The magnitude of this effect was large at both time points as well (d = 1.21
and 1.16, respectively). Second, participants endorsed significantly fewer sensory and
affective descriptions of pain at both time points. Interestingly, the magnitude of this
difference was somewhat less strong than with the BPI measure of pain at both posttreatment (d = 0.75) and 3-months (d = 0.78). Participants also reported significantly
less pain-related disability at both follow-up assessments with a very large effect size at
both time points (d = 1.42 and 1.33, respectively). Additionally, participants not only
reported less pain, they also reported significantly more acceptance of their chronic pain
on a measure that assesses willingness to tolerate pain and to engage in activities
regardless of pain. The magnitude of this change was also large at post-treatment (d =
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0.97) and the 3-month follow-up assessment (d = 1.16). Improvement was also noted
on multiple dimensions of mood and emotional functioning but with more variability in
the magnitude of improvement than with the pain-related measures. First, participants
reported significantly less depression on the CES-D at both follow-up time points
compared with baseline. The magnitude of this change was large at post-treatment (d =
1.04) and somewhat reduced but still large at the 3-month follow-up (d = 0.81). The
global severity index of the BSI, which measures general emotional distress, was also
significantly reduced at follow-up. At post-treatment, this effect size was moderate to
large (d = 0.75) but decreased to a small to moderate effect at 3 months (d = 0.47).
Finally, participants reported significantly fewer symptoms of unresolved stress
symptoms as reflected by cognitive intrusions, cognitive avoidance, and hyperarousal
with respect to a specific stressful event. The moderate to large magnitude of change
on this measure was maintained at both follow-up assessments (d = 0.75 and 0.78,
respectively).
On the final domain assessed, satisfaction with life, participants reported
significantly more general satisfaction with life at post-treatment and at the 3-month
follow-up. However, the magnitude of change for this measure was smaller than the
other outcome measures--the effect size was small to moderate at both time points (d =
0.44 and 0.39, respectively).
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TABLE 1. Baseline, Post-treatment, and Follow-up Data and Analyses of Change
Outcome Measure

BPI Pain
Baseline
Post-treatment
3-month
BPI Disability
Baseline
Post-treatment
3-month
MPQ Sensory Pain
Baseline
Post-treatment
3-month
MPQ Affective Pain
Baseline
Post-treatment
3-month
Pain Acceptance
Baseline
Post-treatment
3-month
Depression
Baseline
Post-treatment
3-month
General Emotional
Symptoms
Baseline
Post-treatment
3-month
Unresolved Stress
Baseline
Post-treatment
3-month
Satisfaction with Life
Baseline
Post-treatment
3-month

Change
from
baseline

t

p

Effect Size (d)

5.49 (1.91)
3.18 (1.86)
3.03 (1.83)

-2.31
-2.32

-7.47
-6.30

< .01
< .01

-1.21
-1.16

6.01 (2.12)
2.99 (2.26)
3.07 (2.31)

-3.02
-2.81

-8.34
-5.46

< .01
< .01

-1.42
-1.33

10.09 (6.71)
5.09 (4.92)
6.20 (4.82)

-5.01
-4.85

-5.16
-3.85

< .01
<.01

-0.75
-0.69

4.00 (3.52)
1.27 (1.30)
2.10 (2.78)

-2.73
-2.23

-4.96
-4.17

< .01
< .01

-0.78
-0.62

47.56 (16.90)
63.90 (18.56)
65.74 (17.96)

16.33
20.00

5.87
4.94

< .01
< .01

0.97
1.16

27.69 (12.20)
15.00 (10.76)
18.31 (13.07)

-12.69
-10.27

-6.33
-4.60

< .01
< .01

-1.04
-0.81

57.54 (32.29)
33.16 (26.46)
45.00 (37.35)

-24.37
-16.05

-6.76
-3.19

< .01
< .01

-0.75
-0.47

29.17 (19.20)
14.68 (10.19)
14.83 (12.74)

-14.49
-15.70

-5.61
-5.18

< .01
< .01

-0.75
-0.78

0.66
0.61

4.01
2.64

< .01
< .05

0.44
0.39

Mean (SD)

3.21 (1.51)
3.87 (1.53)
3.74 (1.60)

Note. Paired sample t-tests and effect size calculation included only those participants who provided data at that
follow-up point. N = 38 at post-treatment and 30 at 3-months for the BPI, Depression, Unresolved Stress, and
Satisfaction with Life measures. N = 37 at post-treatment and 30 at 3-months for the McGill. N = 39 at post-treatment
and 31 at 3-months for Pain Acceptance and General Emotional Symptoms.
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Individual Responder Rates
Individual patient outcomes were also examined using the reliable change index
(RCI), which indicates how much change occurred while accounting for measurement
error across time. These results are presented in Table 2.
On the Brief Pain Inventory, 86.9% of the participants showed at least moderate
effects, with 65.8% of the sample obtaining large effects at post-treatment. Similar
effects were found at the 3-month follow-up assessment; 83.8% showed at least
moderate effects, with 60% of the sample obtaining large effects. The disability items of
the BPI led to similar results as well; 82% of the participants showed at least moderate
effects, with 66% of the sample obtaining large effects. At 3 months, 80% showed at
least moderate effects, with 50% of the sample obtaining large effects.
Consistent with the pattern noted above with statistical significance of the
changes, there were fewer participants demonstrating reliable change on the McGill
Pain Questionnaire than the Brief Pain Inventory. An examination of scores on the
Sensory subscale of the McGill Pain Questionnaire showed that 59% had at least
moderate effects, with nearly 30% of the sample obtaining large effects at posttreatment. Nearly identical outcomes were found at 3 months with 60% obtaining
moderate effects, and 30% of the sample obtaining large effects. Slightly less individual
change was found for the Affective subscale. At post-treatment, 51% showed at least
moderate effects, with 22% of the sample obtaining large effects. This level of
improvement was maintained at 3 months with 50% showing at least moderate effects,
and 17% of the sample obtaining large effects.
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There was substantial improvement in pain acceptance at both follow-up
assessments. At post-treatment, 74% showed at least moderate effects, with 41% of the
sample obtaining large effects. At 3 months, 74% showed at least moderate effects with
45% of the sample obtaining large effects.
Comparable effects were found for the measures of emotional functioning as with
the pain-related measures. On the depression measure, 76% of the participants showed
at least moderate effects at post-treatment, with 58% of the sample obtaining large
effects. Similarly substantial effects were noted at 3 months as well with 77% showing
at least moderate effects. Of the participants, 37% obtained large effects. Regarding
general levels of emotional distress, 77% showed at least moderate effects at posttreatment, with nearly half of the sample (46%) obtaining large effects. At 3 months,
68% still showed at least moderate effects with approximately 1/3 of the participants
(32%) obtaining large effects. On a measure of unresolved stress symptoms, 71%
showed at least moderate effects with 53% of the sample obtaining large effects. These
effects were slightly better at 3 months with 77% showing at least moderate effects and
57% obtaining large effects.
Also similarly to the patterns on the t-tests and effect sizes, there were fewer
positive responses for satisfaction with life than for the other outcome measures. . At
post-treatment, 45% showed at least moderate effects with 13% of the participants
obtaining large effects. At the 3 month follow-up, 47% showed at least moderate effects
with 20% of the sample at this point obtaining large effects.
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Table 2. Reliable Change Index
No Effect
n (%)
BPI Pain
Post-treatment (N = 38)
5 (13.2)
3-month (N = 30)
5 (16.7)
BPI Disability
Post-treatment (N = 38)
7 (18.4)
3-month (N = 30)
6 (20.0)
MPQ Sensory Pain
Post-treatment (N = 37)
15 (40.5)
3-month (N = 30)
12 (40.0)
MPQ Affective Pain
Post-treatment (N = 37)
18 (48.6)
3-month (N = 30)
15 (50.0)
Pain Acceptance
Post-treatment (N = 39)
10 (25.6)
3-month (N = 31)
8 (25.8)
Depression
Post-treatment (N = 38)
9 (23.7)
3-month (N = 30)
7 (23.3)
General Emotional Symptoms
Post-treatment (N = 39)
9 (23.1)
3-month (N = 31)
10 (32.3)
Unresolved Stress
Post-treatment (N = 38)
11 (28.9)
3-month (N = 30)
7 (23.3)
Satisfaction with Life
Post-treatment (N = 38)
21 (55.3)
3-month (N = 30)
16 (53.3)
Note. Large effect = cut off of 1.96; Moderate effect = .50.

Moderate (but not
large) Effect
n (%)

Large Effect
n (%)

8 (21.1%)
7 (23.3%)

25 (65.8)
18 (60.0)

6 (15.8)
9 (30.0)

25 (65.8)
15 (50.0)

11 (29.7)
9 (30.0)

11 (29.7)
9 (30.0)

11 (29.7)
10 (33.3)

8 (21.6)
5 (16.7)

13 (33.3)
9 (29.0)

16 (41.0)
14 (45.2)

7 (18.4)
12 (40.0)

22 (57.9)
11 (36.7)

12 (30.8)
11 (35.5)

18 (46.2)
10 (32.3)

7 (18.4)
6 (20.0)

20 (52.6)
17 (56.7)

12 (31.6)
8 (26.7)

5 (13.2)
6 (20.0)

Predicting changes in outcome
Correlations among the predictor variables. The correlations among the predictor
variables are presented in Table 3. An examination of the correlation matrix reveals
several domains of predictor variables. With the exception of a couple of scattered
significant correlations, depression, the two stress items, and attitudes toward treatment
each represent a separate predictor domain, whereas the emotion regulation measures
(alexithymia, ambivalence over emotional expression, levels of emotional awareness,
and communicating thoughts and feelings questionnaire) represent another domain of
predictors. Aside from the very high correlations among the difficulty identifying feelings,
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the difficulty describing feelings subscales and the total alexithymia score, the majority
of the correlations do not suggest any redundant measures.

Table 3. Intercorrelations among predictor variables
CESD
CESD
TAS20
DIF
DDF
EOT
AEQ
LEAS
CTFQ-A
CTFQ-V
LSCRsum
LSCRdis

.16

CTFA
-.08

CTFV
-.20

.69

-.31

-.48

.36

.75

-.09

.43

.65
.21

TAS20

DIF

DDF

EOT

AEQ

LEAS

LSCRsum

LSCRdis

TASpre

.27

.34

.20

.09

.41

-.07

.26

-.26

.87

.87

.69

-.44

-.05

.29

-.07

.70

-.34

-.43

.13

.33

-.01

-.37

-.48

-.30

-.13

.17

-.13

-.34

-.36

-.37

-.15

.17

-.04

-.15

-.52

-.36

.10

.38

-.14

.28

.20

.44

.22

.19

.48

-.17

-.23

.32

.01

-.12

.29

.31

.04
.04

Note. CESD = Center for Epidemiological Studies-Depression; TAS20 = Toronto Alexithymia Scale total score; DIF =
TAS20 Difficulty Identifying Feelings; DDF = TAS20 Difficulty Describing Feelings; EOT = TAS20 Externally Oriented
Thinking; AEQ = Ambivalence Over Emotional Expression; LEAS = Levels of Emotional Awareness Scale; CTF-A =
Communicating Thoughts and Feelings Questionnaire Assertive Subscale; V = Vulnerability Subscale; LSCRsum =
Life Stressor Checklist Revised Number of Stressful Life Events; LSCRdis = Average Distress Associated with
Stressors; TASpre = Treatment Attitudes Survey
p < .05 when r ≥ ± .30; p < .01 when r ≥ ± .37

A series of partial correlations were used to explore the relationships between
baseline measures of depression, emotion regulation, stress, and attitudes toward
treatment, and the change scores for the outcome measures for both the post-treatment
and the 3-month follow-up. The demographic variables of age and gender were
associated with some of the predictor variables. Thus, these correlations were
controlled for age and gender to eliminate any potential confounds of these
relationships.
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Baseline Depression
Partial correlations were examined between baseline levels of depression and
change in the outcome measures. Overall, baseline depression was a significant
predictor of change in outcome across several domains, and these values are
presented in Table 4. First, with respect to pain-related outcome measures, depression
failed to predict changes in pain as measured by the Brief Pain Inventory at either time
point; however, it predicted change in both the sensory and affective subscales of the
McGill Pain Questionnaire at the post-treatment assessment. Specifically, greater
depression at baseline significantly predicted a greater reduction in the affective
dimension of pain and marginally did so in the sensory dimension of pain. This
relationship was not maintained at the 3-month follow up. Regarding pain-related
disability, greater baseline depression significantly predicted a greater reduction in
disability at post-treatment and marginally did so at 3 months. Finally, baseline
depression failed to predict changes in pain acceptance at both time points.
With respect to the prediction of changes in emotional functioning, baseline
depression was, not surprisingly, related to change in depression and general emotional
distress. Specifically, greater depression at baseline significantly predicted more
improvement in depression at both post-treatment and 3 months, whereas it predicted
more improvement in general levels of emotional distress only at post-treatment.
Greater baseline depression also predicted a greater reduction in unresolved stress
symptoms at post-treatment but not at the 3-month follow-up. Finally regarding
satisfaction with life, greater baseline depression predicted more satisfaction with life at
post-treatment. This relationship was not maintained at 3 months.
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Table 4. Partial correlations (controlling for gender and age) between baseline
depression and changes in outcome measures (post minus pre)
Depression
Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

-.19
-.30
†

-.32
*
-.40

†

-.33
-.17

**

-.50
-.21
.13
.19

**

-.68
**
-.48
**

-.53
-.28

*

-.34
-.06
*

.37
.15

Note. p < .10. p < .05. p < .01

Baseline levels of stress
Stress at baseline demonstrated predictive ability of change in outcome
measures across domains. These values are presented in Table 5. Greater levels of
distress associated with stressful life events at baseline marginally predicted less
improvement in pain-related disability at post-treatment but not at the 3-month follow-up.
In contrast, greater levels of distress at baseline significantly predicted more reduction
in affective dimensions of pain at post-treatment, and number of stressful life events at
baseline marginally predicted more improvement in chronic pain acceptance at post-
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treatment. Similarly, both greater number of stressful life events and greater distress
associated with stressful life events at baseline significantly predicted more reduction in
unresolved stress symptoms at post-treatment. At 3 months, only number of stressful
life events remained a significant predictor. Baseline levels of stress failed to predict
changes in pain on the BPI, depression, general emotional distress, and satisfaction
with life.
Table 5. Partial correlations (controlling for gender and age) between baseline levels of
stress and changes in outcome measures
Stress

Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

Note. p < .10. p < .05. p < .01

Number of Stressful Life Events

Associated Distress

-.04
.05

.11
.18

.02
.21

.30
.26

-.09
.01

-.24
-.02

-.08
-.11

-.40
-.29

.28
.12

†

.27
.12

.01
-.09

.03
.09

-.15
-.12

-.11
.08

-.36
*
-.47

*

-.44
-.32

.25
.28

.11
-.02

†

*

**
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Alexithymia
The total score of alexithymia, along with the separate subscales, demonstrated
some predictive validity with respect to change in the outcome measures. These values
are presented in Table 6. Overall, alexithymia failed to predict changes in pain as
measured by both the BPI and the MPQ. However, greater baseline levels of the
difficulty identifying feelings subscale marginally predicted less improvement in pain on
the BPI at 3 months. In contrast, greater baseline levels of the difficulty describing
feelings subscale marginally predicted more improvement in the affective dimension of
pain on the MPQ at post-treatment. Alexithymia failed to predict changes in pain-related
disability. Finally for the pain-related measures, greater levels of alexithymia at baseline
marginally predicted more improvement in chronic pain acceptance at post-treatment.
Examining the predictive ability of the alexithymia subscales reveals that, specifically,
greater levels of the difficulty identifying feelings subscale significantly predicted more
improvement in pain acceptance. Interestingly, while greater levels of difficulty
identifying feelings predicted less improvement in pain on a 1-10 scale, it predicted
more improvement in chronic pain acceptance.
With respect to the outcome measures of emotional functioning, baseline levels
of alexithymia failed to predict changes in depression and general emotional distress at
both time points. However, greater levels of alexithymia at baseline significantly
predicted a greater reduction in unresolved stress symptoms at post-treatment. Both the
difficulty identifying feelings and the difficulty describing feelings subscales significantly
predicted this change. At the 3-month follow-up, only the difficulty identifying feelings
subscale significantly predicted a greater reduction in unresolved stress symptoms, and
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the difficulty describing feelings subscale marginally did so. On the final measure,
satisfaction with life, there was only one marginally significant prediction found between
the difficulty describing feelings subscale of alexithymia and satisfaction with life.
Specifically, greater levels of difficulty describing feelings marginally predicted less
improvement in satisfaction at the 3-month follow-up. The externally oriented thinking
subscale of alexithymia failed to predict any changes in outcome.
Table 6. Partial correlations (controlling for gender and age) between baseline
alexithymia and changes in outcome measures
Alexithymia

Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

Note. p < .10. p < .05. p < .01

Total
Alexithymia

Difficulty
Identifying
Feelings

Difficulty
Describing
Feelings

Externally
Oriented
Thinking

.18
.20

.22
†
.33

.08
.04

.13
.08

.22
.14

.24
.27

.12
-.10

.16
.17

-.20
.05

-.11
.12

-.21
-.11

-.18
.13

-.23
-.11

-.23
-.18

-.32
-.24

†

.04
.24

.28
.10

†

.36
.06

*

.17
.21

.12
-.06

.04
.21

-.03
.19

.01
.13

.13
.17

-.14
-.11

-.23
-.10

-.17
-.27

.10
.16

*

**

-.41
-.31

-.55
**
-.53

-.41
†
-.33

†

.02
.20

-.03
-.28

.02
-.25

-.16
†
-.35

.09
.01
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Ambivalence over Emotional Expression
In general, ambivalence over emotional expression demonstrated predictive
ability across the domains of outcome measures. These values are presented in Table
7. With respect to the Brief Pain Inventory, baseline ambivalence failed to predict
changes in pain and pain-related disability.

However, greater baseline levels of

ambivalence about expressing emotions significantly predicted greater reductions in
both sensory and affective dimensions of pain at post-treatment and a greater reduction
in the affective dimension of pain at 3 months. Additionally, greater levels of baseline
ambivalence significantly predicted more improvement in chronic pain acceptance at
post-treatment but not at 3 months.
With respect to the measures of emotional functioning, ambivalence over
emotional expression failed to predict changes in depression at follow-up.

Greater

levels of ambivalence at baseline significantly predicted more improvement in general
emotional distress symptoms at post-treatment and marginally so at 3 months. It also
significantly predicted a greater reduction in unresolved stress symptoms at both time
points. Finally, ambivalence over expressing emotions failed to predict changes in
satisfaction with life.
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Table 7. Partial correlations (controlling for gender and age) between baseline
ambivalence over emotional expression and changes in outcome measures
Ambivalence Over Emotional
Expression
Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

.03
.25
.15
.14
*

-.43
-.19

-.53**
*
-.43
*

.36
.17

.12
-.07
*

-.42
†
-.32
**

-.54
**
-.51
.00
-.17

Note. p < .10. p < .05. p < .01

Levels of Emotional Awareness
Baseline levels of emotional awareness only demonstrated predictive ability on
two measures. These values are presented in Table 8. It failed to predict changes in
any of the pain-related measures, depression, and general emotional distress. Greater
levels of emotional awareness at baseline marginally predicted a greater reduction in
unresolved stress symptoms at the 3-month follow-up. There was also a marginally
significant prediction found between emotional awareness and satisfaction with life.
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Greater levels of emotional awareness marginally predicted more satisfaction at both
post-treatment and 3 months.
Table 8. Partial correlations (controlling for gender and age) between baseline levels of
emotional awareness and changes in outcome measures
Levels of Emotional Awareness
Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

.05
-.10
.08
.07
.24
-.02
.26
.08
.18
.08
.11
-.12
-.01
-.11
.05
†
-.36
†

.28
†
.31

**

Note. p < .10. p < .05. p < .01

Communicating Thoughts and Feelings
The

Communicating

Thoughts

and

Feelings

Questionnaire

also

only

demonstrated predictive ability of change in two measures. These values are presented
in Table 9. Both the assertive and the vulnerability subscales failed to predict changes
in pain and pain-related disability on the BPI along with changes in chronic pain
acceptance. On the MPQ, greater baseline levels of assertive ability in communicating
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thoughts and feelings marginally predicted less improvement in the sensory dimension
of pain at post-treatment. Thus, surprisingly, participants who rated themselves as more
assertive at baseline actually reported marginally more sensory pain at outcome than
those who rated themselves as less assertive. A similar prediction was found for
unresolved stress symptoms. Greater levels of assertive ability at baseline significantly
predicted less reduction in unresolved stress symptoms at post-treatment, and greater
levels of ability communicating vulnerable thoughts and feelings marginally predicted
less reduction in unresolved stress symptoms at post-treatment. These relationships
were not maintained at 3 months. Communicating thoughts and feelings failed to predict
changes in depression, general emotional distress, and satisfaction with life.
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Table 9. Partial correlations (controlling for gender and age) between baseline levels of
communicating thoughts and feelings and changes in outcome measures
Communicating Thoughts and Feelings

Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

Assertive

Vulnerability

-.05
-.26

-.14
-.17

.02
-.22

-.02
-.21

.34
-.02

†

.16
-.05

.17
.08

-.12
-.18

-.16
-.04

-.07
-.05

.12
.09

.00
.07

.22
.20

.21
.16

.40
.20

*

.35
.27

-.04
-.10

-.28
-.21

†

Note. p < .10. p < .05. p < .01

Attitudes Toward Treatment
The measure of attitudes toward treatment was predictive of change in only one
outcome measure. These values are presented in Table 10. Greater levels of positive
feelings toward the treatment marginally predicted more improvement in chronic pain
acceptance at post-treatment, but not at the 3-month follow-up. Attitudes toward
treatment failed to predict changes in pain, pain-related disability, measures of emotion
functioning, and satisfaction with life.
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Table 10. Partial correlations (controlling for gender and age) between baseline
attitudes toward treatment and changes in outcome measures
Attitudes Toward Treatment
Pain
Post-treatment (n = 38)
3-month (n = 30)
Pain-related Disability
Post-treatment (n = 38)
3-month (n = 30)
Sensory Pain
Post-treatment (n = 37)
3-month (n = 30)
Affective Pain
Post-treatment (n = 37)
3-month (n = 30)
Pain Acceptance
Post-treatment (n = 39)
3-month (n = 31)
Depression
Post-treatment (n = 38)
3-month (n = 30)
General Emotional Distress
Post-treatment (n = 39)
3-month (n = 31)
Unresolved Stress Symptoms
Post-treatment (n = 38)
3-month (n = 30)
Satisfaction with Life
Post-treatment (n = 38)
3-month (n = 30)
†

*

**

-.27
-.15
-.00
.06
.08
.06
.13
-.03
†

.32
.09

.14
.24
.07
.19
.12
-.03
.11
.05

Note. p < .10. p < .05. p < .01

Evaluating effects of emotional assessment on outcome
The demographic and baseline variables were examined to determine any
differences between the participants who received the novel emotional communication
assessment and those did not receive the assessment. There were no significant
differences between the groups on age, gender, and ethnicity, although age showed
some trend of difference between the two groups, F(1, 43) = 1.78, p = .19. Those who
received the assessment were slightly older than those who did not. See Table 11 for
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the demographics of each group. There were also no significant differences between
groups on the baseline outcome measures. These analyses are presented in Table 12.
A series of ANCOVA’s were conducted to determine whether the participants
who received the novel emotional communication assessment had greater improvement
on the outcome measures than participants who did not receive the assessment. Group
was used as the independent variable, and the change scores at post-treatment and 3months were used as the dependent variable. Because age was slightly significantly
different between the two groups it was entered as a covariate for these analyses.
These analyses were conducted separately for the post-treatment and 3-month followup assessments. At post-treatment and at the 3-month follow-up, the ANCOVA’s
revealed no significant differences between the two groups. There was one trend for
significance in the opposite direction than hypothesized for satisfaction with life at 3
months. Participants in the group receiving the novel assessment tended to report less
satisfaction with life than the participants who did not receive the assessment, F(1, 27) =
3.48, p = .07. The complete results of the baseline, post-treatment, and 3-month followup data and the ANCOVAs are presented in Table 12.

Table 11. Comparison of Demographic Variables Between Those Who Received The
Emotion Assessment and Those Who Did Not.
Age (years)
Gender
Female
Male
Ethnicity
Caucasian
African American
Middle Eastern
Unknown

2

F/χ

p

1.78

.19

18 (75.00%)
6 (25.00%)

.03

.86

23 (95.83%)
1 (4.17%)
0 (0.00%)
0 (0.00%)

.52

.47

M (SD)

Assessment
(n =22 )
54.29 (14.60)

No Assessment
(n = 24)
48.09 (16.06)

n (%)
n (%)

17 (77.27%)
5 (22.72%)

n (%)
n (%)
n (%)
n (%)

19 (90.48%)
0 (0.00%)
1 (4.76%)
1 (4.76%)
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Note. Chi-square analysis for ethnicity was analyzed comparing Caucasian to the other ethnicities
combined due to the small numbers in the other cells.

Table 12. Baseline, Post-treatment, and Follow-up Data and Analyses of Change by
Group.
Assessment

BPI Pain
Baseline
Post-treatment
3-month
BPI Disability
Baseline
Post-treatment
3-month
MPQ Sensory Pain
Baseline
Post-treatment
3-month
MPQ Affective Pain
Baseline
Post-treatment
3-month
Pain Acceptance
Baseline
Post-treatment
3-month
Depression
Baseline
Post-treatment
3-month
General Emotional
Distress
Baseline
Post-treatment
3-month
Unresolved Stress
Baseline
Post-treatment
3-month
Satisfaction with
Life
Baseline
Post-treatment
3-month

n

M (SD)

21
19
15

5.35 (2.07)
3.16 (1.81)
3.49 (1.93)

21
19
15

No Assessment
Change
Score

F

p

n

M (SD)

Change
Score

-2.19
-1.86

24
20
16

5.23 (1.91)
3.21 (1.91)
2.72 (1.68

-2.02
-2.51

.04
.21
.03

.85
.65
.87

5.92 (2.20)
3.11 (2.04)
3.85 (2.68)

-2.81
-2.07

24
20
16

5.60 (2.23)
2.93 (2.46)
2.40 (1.62)

-2.67
-3.20

.23
.16
.04

.63
.69
.84

22
18
15

10.40 (7.10)
5.79 (6.34)
8.11 (5.19)

-4.61
-2.29

23
20
16

9.90 (5.68)
5.15 (4.42)
4.46 (3.61)

-4.75
-5.44

.07
.31
.48

.80
.58
.50

22
18
15

4.50 (3.76)
1.22 (1.26)
2.73 (3.13)

-3.28
-1.77

23
20
16

3.65 (2.92)
1.60 (1.85)
1.56 (2.28)

-2.05
-2.09

.72
.69
.03

.40
.41
.86

22
19
15

50.68 (17.39)
64.47 (18.76)
63.20 (18.74)

13.79
12.52

24
20
16

46.25 (16.78)
63.35 (18.84)
68.13 (17.45)

17.10
21.88

.77
.46
.60

.38
.50
.45

21
19
15

27.35 (12.15)
14.26 (9.83)
22.74 (12.83)

-13.09
-4.61

24
20
16

27.72 (12.42)
15.10 (11.88)
13.50 (11.81)

-12.62
-14.22

.01
.01
2.19

.92
.91
.15

22
19
15

59.10 (32.88)
33.93 (26.01)
51.33 (43.94)

-25.17
-7.77

24
20
16

57.54 (30.39)
32.42 (27.53)
39.06 (39.66)

-25.12
-18.48

.03
.23
.11

.87
.64
.74

22
19
14

29.43 (19.46)
13.47 (8.11)
18.43 (15.23)

-15.96
-11.00

24
19
16

29.38 (17.06)
15.89 (12.03)
11.69 (9.49)

-13.49
-17.69

.00
.42
.03

.99
.52
.87

21
19
15

3.13 (1.53)
3.69 (1.65)
3.12 (1.44)

0.56
-0.01

24
20
16

3.08 (1.40)
4.15 (1.45)
4.34 (1.50)

1.07
1.26

.02
2.43
3.48

.90
.13
.07
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Chapter 4
Discussion
This study sought to extend the literature on the effects of emotion-focused
treatments for chronic pain by examining a four session group treatment that utilizes
emotionally oriented techniques to treat pain. This study had three goals. First, it tested
the hypothesis that this treatment would be effective by examining the pattern,
magnitude, and reliability of change from baseline to post-treatment and 3-month followup on pain, pain-related disability, pain acceptance, emotional functioning (depression
and general emotional distress), and satisfaction with life. Second, the study examined
the ability of baseline measures of depression, stress, emotion regulation ability, and
treatment attitudes to predict outcome of the treatment. Finally, this study included a
novel emotional assessment that examined the participants’ ability to communicate
thoughts and feelings. It was hypothesized that participants who received this emotional
assessment would report more improvement on the outcome measures than the
participants who did not receive this assessment.
Estimating Changes in Outcome
To determine the effects of the intervention on the outcome measures of pain,
pain-related disability, pain acceptance, emotional functioning, and satisfaction with life,
several sets of analyses were conducted. These analyses, in general, indicated that this
intervention led not only the statistically significant but clinically meaningful
improvements in the outcome measures. First, paired-samples t-tests demonstrated
that the mean scores of the outcome variables were statistically improved from the
baseline values at both post-treatment and the 3-month follow-up assessment. Thus,
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this intervention “works” in the sense that there was improvement, on average, among
the patients.
More important than demonstrating that the effects are reliably different than
zero, is estimating the magnitude of the effect of the intervention. Across measures, the
sample’s improvement across time ranged from 0.39 to 1.42 standard deviations from
baseline to post-treatment and a 3-month follow-up. These effects range from smallmoderate to very large. This large variation in effect size may be due in part to the
variability of domains of functioning assessed. Overall, the most improvements were
found in the domain of pain, pain-related disability, and chronic pain acceptance, with
improvements ranging from 0.62 to 1.42 standard deviations from baseline to posttreatment and the 3-month follow-up. Both the pain and the disability subscales of the
Brief Pain Inventory demonstrated over 1 standard deviation improvement from baseline
to post-treatment and the 3-month follow-up assessment.
Interestingly, the sensory and affective dimensions of pain did not demonstrate
as large of an improvement (.62 - .78 SDs). Even though both of these measures
assess perception of pain, they actually assess different elements of pain. The BPI
requires participants to rate their pain on a 0-10 scale with 10 indicating the greatest
level of pain whereas the MPQ requires participants to rate how much various sensory
and affective adjectives describe their pain. Overall pain intensity decreased as
demonstrated by decreased ratings on the 0-10 scale. Yet, participants still reported
experiencing pain at the post-treatment and 3-month follow-up, thus, they still rated
some of the pain adjectives as descriptive of their pain, importantly, with less intensity.
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Finally, in regard to the pain domain, large effects were demonstrated in painrelated functioning. First, participants reported over 1 SD improvement at both posttreatment and the 3-month follow-up on pain-related disability. Participants reported
substantial improvement for interference from pain in the areas of general activity,
mood, mobility, and normal work levels at follow-up than at baseline. Additionally,
participants reported large improvements at both follow-up assessments in their level of
pain acceptance, which includes an acceptance of experiencing chronic pain along with
a willingness to engage in activities regardless of pain experience.
These large improvements in pain and pain-related functioning are even more
impressive when considering the brief nature of this treatment. One would not expect
such significant benefits following only four sessions of a group format. Even though this
is an uncontrolled study, this level of pain improvement would not be expected to
happen on its own, with simply the passage of time. Moreover, comparing the effects of
this intervention to the benefits noted for pain in other psychological treatments of pain
reinforces the effectiveness of this treatment. Many studies do not find such substantial
improvement in pain. Keefe, Caldwell, Williams, and Gill (1990) reported a median
effect size of 0.50 of cognitive-behavioral treatments, but many of the studies examining
CBT show even smaller effects with significantly less improvement noted at later followups as compared to post-treatment effects. Studies of written emotional disclosure show
modest benefits at best for pain with many of these studies demonstrating small effects
for pain and other medical conditions (Broderick et al. 2005; Frisina et al. 2004; Gillis et
al. 2006 Meads et al. 2003). Lumley and colleagues (2008) evaluated an emotional
exposure based treatment for patients with fibromyalgia and found small to moderate
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effects on the sensory and affective domains of pain at post-treatment and a 3-month
follow-up. Thus, the moderate to large and large effect sizes found for pain in this
emotion focused treatment at both post-treatment and at a 3-month follow-up are
extremely note worthy.
Moderate to large improvements were also found for measures of emotional
functioning. With the exception of the 3-month effect for general emotional distress (d =
.47), improvement for measures of depression, general distress, and unresolved stress
symptoms ranged from approximately 0.75 standard deviation to just over 1 standard
deviation from baseline to post-treatment and a 3 month follow-up. Even though these
effects are not quite as large as the improvements in pain, they are still substantial
improvements. Particularly noteworthy are the large effects found in depression and the
somewhat smaller effects in unresolved stress symptoms, even three months following
this short-term group treatment. These results are partially expected because these are
the symptoms targeted by this intervention. A key part of the treatment involves
expressing emotions and processing unresolved stressful experiences through writing.
Additionally, it uses mindfulness techniques to guide acceptance of emotions and
thoughts as normal and not harmful and reengaging in previously avoided activity
scheduling to help patients re-engage with life. These techniques serve to counter the
avoidance of stressful thoughts and emotions that are hypothesized to relate to chronic
pain.
It is important to note that even though the effect size for depression remained large
at the 3-month follow-up and was nearly a medium effect for general emotional distress
at 3 months, these measures had the largest reduction in improvement between post-
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treatment and the 3-month follow-up. It is not surprising that some of the substantial
treatment gains noted immediately after this brief treatment would be reduced
somewhat after several months. With the exception of chronic pain acceptance and
unresolved stress symptoms, which increased slightly in effect size, slight decreases
are found across the measures. However, regarding depression and general emotional
distress, it may be that some patients had diagnosable depressive and/or anxiety
disorders that would not be expected to remit after 4 sessions of group treatment.
Surprisingly, the least improvement was found for satisfaction with life, which was a
small to moderate effect at both post-treatment and 3 months. Given the substantial
improvements in pain and pain-related disability along with depression and stress
symptoms, one would expect greater improvements life satisfaction than what the
participants reported at the follow-up assessments. It may be that even though the
participants demonstrated improved depression, they still are experiencing a significant
level of depression. An examination of the average depression scores shows that, in
general, this sample was very depressed at baseline. Thus, even after substantial
improvement (baseline mean = 27.69; post-treatment mean = 15.00; 3-month follow-up
mean = 18.31), participants are still reporting levels of depression just under the cut-off
for this measure at post-treatment and just over the cut-off at the 3-month follow-up.
Additionally, many of these participants have been dealing with chronic pain for years
and may have more of a negative outlook on life. They may still fear that the
improvements in the pain-related domains are temporary and have not yet made many
changes in their lives. Furthermore, similarly to the remaining symptoms of depression,
pain improved substantially but not completely (baseline mean = 5.49; post-treatment
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mean = 3.18; 3-month mean = 3.03). Some of the participants may only think that a
complete cessation of pain is successful. As long as they are still experiencing pain, life
is not as satisfying as it could be. In addition, quality of life is not just thought of as the
inverse of negative states such as depression or pain. With the consideration of life
satisfaction as partially independent from the other outcomes, it may be that the patients
are experiencing reduced symptoms but still are not reporting the addition of many
positive elements in their lives. Life satisfaction may require positive developments in
sense of self, relationships, and meeting life’s goals.
Finally, in addition to estimating change across the sample, this study examined the
number of individual patients who show a clinically meaningful positive change after
completing the treatment. A similar pattern of change was found when looking at
individual change as with the range found on the group effect sizes. The percentage of
individual patients demonstrating a reliably large effect ranged from 13% to 66%. The
highest prevalence of clinically significant responders was found on pain and painrelated disability rated on a 0-10 scale. Nearly 2/3 of the sample had a large effect (less
than 5% probability that the change is due to chance) at post-treatment for both of these
outcomes. At the 3-month follow-up, 60% of the sample still had a large effect on this
measure of pain, and half of the sample still had a large effect for pain-related disability.
When using a less stringent cut-off to identify a moderate effect, the level of individual
change was even more impressive. Over 80% of the sample had at least a moderate
effect for pain at both follow-ups and approximately 80% had at least a moderate effect
on pain-related disability. These high percentages suggest that the clinically meaningful
improvements in pain and pain-related disability occurred for the majority of the sample

61
which is much higher than the 1/3 of patients Turk (2005) found improved on average
with cognitive-behavioral treatments for pain. Chronic pain acceptance was a similarly
robust change across both time points. Almost half of the sample had a large effect at
the 3-month follow-up. Including the moderate effect, ¾ of the sample demonstrated
clinically meaningful improvements in pain acceptance. Lower rates of improvement
were found on the sensory and affective dimensions of pain, which is consistent with the
lower effect size noted for the group overall, and again suggests that this manner of
measuring pain differs from the 0 to 10 rating scale of pain intensity.
Regarding the measures of emotional functioning, with the exception of the
unresolved stress symptoms, more individuals showed improvements at the posttreatment than at the 3-month follow-up (depression and general emotional distress).
This reduction in the number of responders at the further follow-up assessment provides
further support for the possibility discussed above that a subset of the patients were
clinically depressed or anxious and may have experienced a short-term significant
benefit from these symptoms. Yet, it is also possible that since 3 months has passed
since the patients’ last assessment, that some of them have experienced stressful
events and become more depressed or anxious. Over half of the participants had a
large effect for unresolved stress symptoms and nearly ¾ of the sample demonstrated a
moderate effect at both time points. As discussed previously, this improvement is
partially expected given the treatment’s emphasis on processing stressful experiences.
As with the previous analyses, the lowest prevalence of clinically significant
responders was found for satisfaction with life. Approximately half of the sample
demonstrated at least a moderate effect, but half of the sample did not demonstrate
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moderate improvement on this outcome. Thus, with the exception of life satisfaction, the
impressive prevalence of individual change on the primary outcomes of pain,
depression, and unresolved stress symptoms provides even more support for the
effectiveness of this treatment.
Predicting changes in outcome
The second goal of the study was to identify variables at baseline that predict
how patients will respond to the treatment. All of the hypothesized predictor variables
demonstrated some predictive ability. In general, participants with greater levels of
depression, stress, and discomfort with emotions at baseline improved the most.
However, there are several caveats. Many of the predictions were significant only at
post-treatment and not at the 3-month assessment, several of the baseline measures
predicted change in only a few outcomes, and some of the outcomes, such as
improvements in pain, were not predicted by any of the baseline measures.
First, depression demonstrated strong predictive validity at the post-treatment
assessment. Participants who reported greater depression at baseline reported greater
improvements in pain-related disability, the sensory and affective dimensions of pain,
depression,

general emotional functioning,

unresolved

stress

symptoms,

and

satisfaction with life at post-treatment. At 3 months, baseline depression significantly
predicted only improvement in depression and marginally predicted improvement in
pain-related disability. These results are consistent with one study that found high levels
of negative affect at baseline to predict better outcomes of written emotional disclosure
(Norman et al., 2004). There are a couple of possibilities regarding the loss of predictive
power at 3 months. First, after examining the partial correlations, a couple of the
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correlations between depression and the outcome measures may have been significant
with a large sample size (pain, general emotional distress). However, this is not true for
all of the correlations. Thus, another possibility is that because the overall effects of the
treatment are lower at the 3-month follow-up, there is less change to predict than at
post-treatment. Alternatively, it may be important to consider other factors that may
influence long-term benefits of this treatment. The patients may have made changes in
their lives that account for the improvements noted at 3 months more so than baseline
levels of depression before the treatment.
Second, stress predicted change in outcome for several domains of functioning.
For the most part, greater stress at baseline predicted improvement in the affective
dimension of pain, chronic pain acceptance, and unresolved stress symptoms. Only the
prediction for unresolved stress symptoms was maintained at 3 months. It makes sense
that participants with more stressful experiences to process benefitted from the writing
and meditation exercises. Surprisingly, greater distress associated with stressful life
events at baseline actually predicted less improvement in pain-related disability at posttreatment. It is unclear why this prediction is in the opposite direction as the others with
stress and depression. An examination of the correlations between stress and the
outcome measures suggests that, in general, a larger sample size would likely provide
enough power to maintain these predictions.
Third, an examination of the emotion regulation measures revealed variable and
sometimes conflicting predictive ability of changes in outcome. Alexithymia as a total
score predicted change only in unresolved stress symptoms. Greater alexithymia at
baseline predicted improvement in unresolved stress symptoms at post-treatment and
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marginally predicted improvement at 3 months. However, the subscales of difficulty
identifying feelings and the difficulty describing feelings had variable results. Whereas
greater levels of difficulty describing feelings at baseline predicted improvement in the
affective dimension of pain at post-treatment, it predicted less improvement in
satisfaction with life at 3 months. Also in contrast to the improvement in affective pain,
greater levels of difficulty identifying feelings at baseline predicted less improvement in
pain on a 0-10 scale at 3 months. It is unclear why the describing feelings and the
identifying feelings components of alexithymia would predict a different direction in
similar outcomes. Furthermore, it is interesting that participants reporting more difficulty
identifying and describing emotions would have greater improvement in unresolved
stress symptoms, yet still have less improvement in pain and satisfaction with life.
These mixed results are consistent with much of the literature on alexithymia as it
relates to health and psychological outcomes with several studies concluding that
alexithymia predicts poorer outcome (Kelley et al., 1997; Posemato, 2008), yet other
studies showing more benefits for alexithymic individuals (Baikie, 2008; Solano et al.,
2003).
Regarding levels of emotional awareness, greater awareness at baseline
marginally predicted improvement in unresolved stress symptoms at 3 months and in
satisfaction with life at both time points. However, greater perceived ability to express
assertive and vulnerable thoughts and feelings at baseline predicted less improvement
in the sensory dimension of pain and unresolved stress symptoms at post-treatment.
Thus, it is somewhat confusing that a greater awareness of emotions and being
alexithymic at the same time led to a greater reduction in unresolved stress symptoms,
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but a greater perceived ability to communicate emotions led to less reduction in stress
symptoms.
Ambivalence over emotional expression yielded the most consistent predictive
ability with greater baseline levels predicting improvements in pain acceptance at posttreatment, and improvements in the sensory and affective dimensions of pain, general
emotional distress, and unresolved stress symptoms at both time points. These findings
are consistent with another study that found that greater levels of ambivalence at
baseline predicted improved outcomes following the emotion focused treatment of
emotional disclosure (Norman et al., 2004). Overall, with respect to the emotion
regulation predictors, it makes sense that difficulty identifying feelings or less awareness
of emotional experience would interfere with the beneficial outcomes of this treatment.
This is consistent with other research that examined lack of emotional awareness as a
predictor of worse treatment outcome (Kelley et al., 1997; Lumley, Tojek, & Maclem,
2002). Participants may not be able to fully engage in the processing of emotions
related to their stressful experiences. However, for those participants who generally
have an awareness of their emotions but are ambivalent about expressing them or have
difficulty expressing them, this treatment likely facilitated that process through writing
exercises in a safe environment.
Finally, attitudes toward treatment at baseline did not demonstrate much
predictive utility. In fact, greater positive feelings toward the treatment only marginally
predicted improvement in chronic pain acceptance. The lack of findings for this predictor
was surprising given that treatment expectancy and credibility are thought to be strong
predictors of treatment outcome. The average rating for this scale was 2.68 on a 0-4
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scale, suggesting that patients had positive expectations overall regarding the
treatment, yet there was some variability on this measure. Thus, it is also possible that
patients’ ideas about the treatment when they do not fully understand the treatment lack
validity for predicting outcome.
Depression and ambivalence over expressing emotions demonstrated the most
predictive utility regarding who benefits most from this treatment. Even with these
measures, most of the predictions were significant at post-treatment, with only marginal
or no significance at 3 months. As discussed above, it is possible that the reduced
sample size at the 3-month follow-up compared with the post-treatment assessment
could account for these differences. There may not have been enough power to
maintain the predictive ability at 3 months. The magnitude of some of the correlations
suggests that the prediction may be maintained with a larger sample size. However, it is
also possible that different factors account for the improvement at 3 months.
Evaluating effects of emotional assessment on outcome
The third hypothesis that the patients participating in the emotion communication
exercise would report better outcomes at follow-up than those that did not complete the
assessment was not supported. There are several possible explanations for the lack of
group differences on outcomes. There may not be enough power to detect group
differences with the small sample size in each group. The emotion assessment was
brief and may not have been powerful enough to lead to better outcomes. The actual
exercise only took approximately 10 minutes to complete. Furthermore, participants
were not given feedback on their performance but rather were invited to explore how
their performance in the exercise related to their life, stressors, relationships, and pain.
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This exploration may not have been direct enough for the participants to make the
connection between their experiences during the exercise and their past stressful
experiences, emotions, and their current symptoms during the treatment sessions. Even
though challenges in communicating the thoughts and feelings may have been
uncovered during the exercise, participants may not have addressed these challenges
during the treatment. It is also possible that this emotion exercise might be useful as an
assessment tool but may not be as useful for treatment. Finn’s (1996; 2003) work on
therapeutic assessment, which this emotional assessment was partially based on,
involves a more extensive exploration and feedback process. In contrast, the exercise in
this study was only 10-15 minutes in length, and the exploration part was only several of
those minutes. It may be relevant to help patients increase their awareness and
expression of these emotions in preparation for treatment but with a more structured
feedback process.
A surprising finding was that the participants who completed the emotion
assessment actually reported marginally significantly worse outcomes on satisfaction
with life at both time points. However, the reliability of these findings is unclear. There
were no significant differences for the other measures. It does not make sense that the
participants in this group would report similar symptoms at post-treatment and then
worse outcomes three months later. Rather, this is likely explained by the smaller
sample size at 3 months than at post-treatment. Analyses were completed before the
full sample completed their 3-month follow-up. With their data included, it is likely that
these differences will be nonsignificant.
Limitations
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Many of the limitations of this study have been referenced above in relationship
to the applicable hypotheses including lack of control group and small sample size. The
initial goal of this study was to estimate the treatment’s effectiveness. T-tests and effect
sizes revealed that participants reported several large and moderate effects on most of
the domains of functioning after completing the treatment. However, because this was
an uncontrolled study, one cannot conclude that the treatment caused these
improvements. Thus, it is possible that other factors were responsible for the
improvements in functioning. The passage of time, attention of a caring professional,
and expectations/beliefs that they should feel better could account for improvements in
outcome. Furthermore, since all of the outcomes are self-report measures, there are
demand effects on the outcomes. However, as discussed above, it is unlikely that these
factors alone would contribute to this level of improvement given the nature of chronic
pain, which rarely alleviates on its own in such a short period of time and has not
typically found to improve this much in previous studies of chronic pain treatment. The
lack of control group presented another limitation with regard to identifying who benefits
the most from treatment. Without a control group, this study used correlational analyses
to predict improvement following the treatment. With the inclusion of a control group one
can use a moderation analysis to examine interactions between the groups. This type of
analysis can help elucidate more fully how the predictor relates to outcome by showing
how a predictor like ambivalence over emotional expression predicts different outcomes
in a treatment vs. a control group. For example, greater ambivalence may predict better
outcomes in the treatment group but predict poorer outcomes in the control group. The
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current design, however, cannot distinguish whether a measure predicts responses to
this treatment, or just changes in outcomes in general.
Also discussed previously, the small sample size was a limitation for the last two
hypotheses in this study. Regarding the second hypothesis which examined the
predictive ability of the baseline measures, a reduced sample size at the 3-month
follow-up may have contributed to the lack of predictive ability at that time point. With a
larger sample at 3 months, it is possible that some of the significant predictors of
change in outcome at post-treatment would be maintained at 3 months. Furthermore, as
discussed above, the small sample size may have limited the ability to find differences
between the group who completed the emotion assessment exercise and the group who
did not. The reason for the small sample size presents another limitation. Recruitment
began in the fall of 2008 and continued through spring of 2010.Unfortunately, referrals
for the treatment program reduced significantly and, thus, recruitment was slower than
expected and after this spring was stopped with a smaller sample than expected.
Because Dr. Schubiner is the only current provider for this treatment, it was not possible
to collect participants from other clinics. Another factor that contributed to the smaller
sample size was missing data. Some of the measures were missing on several
participants or were not able to be scored because of incomplete responding.
Therefore, some of the analyses included less participants than were actually included
in the study.
Selection bias is another important consideration for this treatment and could
potentially limit the results. It is a select group of patients who are referred for this
treatment program in the first place, usually those whose providers are most frustrated
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with treating them. However, this factor could also provide further support for the
effectiveness of this study if the treatment is this beneficial for the most complicated
patients. Another important aspect of selection bias is particularly relevant for this
treatment. Starting with the initial evaluation, Dr. Schubiner informs the patient about
mind body syndrome and how it is necessary to refute medical explanations for pain
and to accept emotional explanations. Some patients may be resistant to this theory,
and therefore, not complete the treatment. Moreover, it is a subset of those patients
who will agree to participate in a research study. In this study, 37% of the patients
referred for the study did not participate. Some of these patients did not participate
because of logistical reasons including becoming illegible after not participating in the
treatment and not being able to schedule them for the assessment before the treatment
started. However, approximately half of this percentage expressed a lack of interest,
and these patients are likely different in important ways from those patients who are
interested in research. It is possible that they may not have been as invested in the
treatment and may not have benefitted as much.
A final limitation regarding the progression of the treatment program is that the
treatment actually begins with the initial evaluation with Dr. Schubiner when he explains
his model for chronic pain and encourages patients to read about mind body syndrome.
In an attempt to account for this process, key outcome measures were mailed to the
patients prior to their evaluation; however, most of the baseline measures were
completed after the patients met with Dr. Schubiner.
Additionally, although this sample included an adequate number of male patients,
it was a primarily Caucasian sample which limits generalizability of the findings. Also,
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another limitation could be the reliance on self-report measures in this study. Self-report
measures are useful but the study could have been strengthened with the inclusion of
an objective measure of pain tolerance or the observations of another person.
Future Research
Other than the ideas discussed previously, including the utilization of a
randomized controlled design, a larger, more diverse sample, and the incorporation of
objective measures of improvement, future studies should continue to explore potential
moderators of predictors of treatment outcome. This study found support for using
depression and ambivalence over emotional expression as predictors of change in
outcome, but many of the other predictors had scattered and sometimes inconsistent
results. Re-examining these predictors in a larger, more diverse sample will help
determine their utility as predictors. Also, this study did not assess beliefs about pain or
specific measures of pain coping as typically measured in cognitive-behavioral
treatment studies. It would be interesting to compare the predictive ability of these
measures with the emotion regulation measures used in this study. It would also be
valuable to directly compare this intervention with a cognitive-behavioral intervention to
see if this treatment does cause greater improvement in symptoms than CBT.
Additionally, this study attempted to determine who benefits from this treatment
but future studies should address how this treatment might work. This treatment
consists of six components: reading about mind body syndrome, repudiating physical
explanations for symptoms, writing exercises, reflecting with meditative exercises,
reprogramming the mind, and rebuilding the life. Over four weeks, patients are
instructed to complete daily exercises of writing, meditation, and behavioral activation.
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This study demonstrated that patients reported improved outcome after completing
these exercises. However, it is unknown how these components lead to change. One
possibility is that patients are processing avoided emotions and unresolved stressors,
and that changes in these domains are responsible for improvements in pain, disability,
and emotional functioning. Yet another possibility is that patients are increasing their
self-efficacy to make changes and cope with their pain or that they are changing the
way that they think about their pain. Future studies should evaluate these variables over
the course of treatment to see how they relate to changes in outcome. Similarly,
dismantling studies would be beneficial to evaluate which of these components are
most influential on outcome. It is likely that each of these components is not equally
effective. Moreover, some patients may be responsive to different components.
Further exploration of using the novel emotion assessment as preparation for
treatment is also warranted. It will be important to address the limitations described
above including a sample size with sufficient power to detect group differences. This
exercise could also be a useful predictor of treatment outcome and would provide an
objective assessment of emotional expressive ability. Given the conflicting results found
with the self-report emotion regulation predictors in this sample, it would be interesting
to see how an objective measure of ability related to change in outcomes. Another goal
for future research will be to evaluate this treatment program when facilitated by
providers other than Dr. Schubiner. It is possible that, because he created the program
and strongly advocates it, part of the beneficial outcomes is due to his charisma and
belief. He has also published a comprehensive, self-explanatory treatment workbook
that patients can complete on their own. Future studies could evaluate the effectiveness
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of completing this treatment without the guidance and interaction with a facilitator.
Alternatively, research has shown than when participants benefit more from written
emotional disclosure when they know their writings will be read by someone (Radcliffe
et al., 2007). Thus, including a sharing component in the group where people disclose
their stressful experiences and related emotions could prove beneficial.
In conclusion, this study suggests that Schubiner’s treatment is very effective for
patients with chronic pain. In fact, this brief, group treatment led to substantial
improvements in pain and pain-related disability as well as improvements in emotional
functioning. Furthermore, this study contributed to the growing movement that seeks to
identify differential response to treatment for chronic pain. Patients with significant
depression who were aware of their emotions but uncertain about expressing them
benefitted most from this treatment. These results provide further support for the theory
that stressful experiences, poor emotion regulation skills, and emotional disorders relate
to chronic pain and that, more importantly, addressing these elements in an emotionfocused treatment program results in improvements in unresolved stress, emotional
functioning, and in chronic pain.
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APPENDIX A (Informed Consent)

St. John Health/Providence Hospital and Medical Centers
CONSENT TO PARTICIPATE IN A RESEARCH STUDY
AND
AUTHORIZATION TO USE OR DISCLOSE PROTECTED HEALTH INFORMATION
FOR RESEARCH
TO BE CONDUCTED
AT
PROVIDENCE HOSPITAL AND MEDICAL CENTERS

Title: Evaluating a Chronic Pain Treatment Program
Principal Investigators:

Howard Schubiner, M.D., Providence Hospital
Office Phone: (248) 849-4728
Mark A. Lumley, Ph.D. Wayne State University
Office Phone: (313) 577-2773

Sub-Investigators and/or Study Staff:

Amanda Burger, M.A., Wayne State University
Maren Hyde, Wayne State University
Alaa Hijazi, Wayne State University

Background and Purpose
This form contains information about a research study. You understand that you are being asked
to participate in a research study sponsored by Providence Hospital and Wayne State University.
If you choose to participate in this research study, you should clearly understand all information
contained in this consent before you agree to participate by signing your name to the last page.
After you sign the form, you will be given a copy, and an additional copy will remain in your
medical chart.
You understand that this is a research study. You have been asked to participate because you are
a patient with a chronic pain problem and you plan to participate in a treatment program offered
by Dr. Howard Schubiner at Providence Hospital and Medical Center. All subjects participating
in research must volunteer, and be informed about the purpose, risks, benefits if any, and
alternatives. If you have any questions about this research or the document, please ask.
The purpose of this study is to a) evaluate how well Dr. Schubiner’s treatment program works
for people with chronic pain problems, determine which patients are most likely to benefit, and
test the effects of a communication exercise.
Study Description, Location, and Duration
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If you choose to take part in this study you will be asked to come to the hospital two times to
complete some questionnaires and be interviewed about your pain, functioning, stress, and
relationships. These two visits will occur before and soon after you participate in Dr.
Schubiner’s treatment program. The first session at the hospital will take approximately 2 hours.
In addition to completing various questionnaires, half of the patients will be asked to participate
in a communications exercise and discussion, which will take about 15 minutes. If you are
randomly assigned to this exercise (like by the flip of a coin), then you will be asked to
demonstrate how you might communicate different feelings to someone, such as being assertive,
or telling someone that you care. At the end of this exercise, you will be asked to answer several
interview questions about your communication style, emotions, and pain. This communications
exercise will be audiotaped. There is a 50-50 chance that you will be asked to do this
communications exercise.
After the first session, you will then participate in the treatment program just as you would have
if you were not participating in this study. Within a few weeks of completing the treatment
program, you will return to the hospital to complete questionnaires about your health, pain, and
mood, and you will be interviewed about your reactions to the treatment program. This session
will take approximately 1 hour.
Finally, in order to evaluate the outcomes of the treatment over time, we will mail you follow-up
questionnaires 3 months and 6 months after the program ends, and ask you to report again on
your pain, health, and stress by returning the questionnaires in a stamped envelope that we
provide. These questionnaires should take about 20 minutes each.
Approximately 100 people will be in this study. Your total participation will be about 4 hours
over a time span of seven to eight months. Your part in the study will be completed once you
have returned the final packet of questionnaires six months after you have completed the
treatment program.
Possible Risks and Discomforts
We expect the risks of your participating in this study to be minimal and unlikely. However, you
may experience a negative mood when questionnaires and/or interviews ask to you think about
experiences that may have been difficult for you. You may consult Dr. Schubiner or ask the
research team for a referral if you experience such discomfort. There may be other risks that are
unknown at this time.
Benefits
There may be no direct benefit to you in participating in the study. It is possible that you may
learn new things about yourself and experience improvements in your health, pain, and mood. In
the future, other patients may benefit from the results of this study, when they become known.
Alternative Treatments
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An alternative is to not participate. You do not have to participate in this research study in order
to receive Dr. Schubiner’s treatment program for your chronic pain.
Voluntary Participation
You understand that your participation in this study is voluntary and that your refusal to
participate will cause no penalty or loss of benefits that you would otherwise receive. If you
decide to participate, you may change your mind about being in the study, and may quit at any
time without penalty or loss of benefits regarding your future care. If new information becomes
available during the study that may affect your willingness to continue in the study, your doctor
and/or his/her associate will discuss this information with you. Also, your doctor may stop your
participation at any time if he/she feels that is in your best interest.
Compensation
You will receive a total of $100 for completing all four assessments. You will receive $50 for
completing the first 2-hour assessment at the hospital, $30 for completing the 1-hour assessment
at the hospital, and $10 each for completing each of the mailed questionnaire packets three and
six months later. Because the treatment program is not part of the research study you will not
receive any compensation for completing treatment, and you or your insurer will need to pay for
the treatment.
No funds have been set aside for injured research subjects. While medical care is available
should an injury occur, the cost will be billed to you or your insurer in the ordinary manner.
Confidentiality Of Records
The principal investigators will have access to your medical records and your test results. While
absolute confidentiality cannot be guaranteed, you understand that all medical records and
research material that could identify you will be kept as confidential as possible within state and
federal laws. However, you risk the loss of confidentiality if you are thought to be at risk for
self-harm or harming another, if there is a concern that child abuse or elder abuse has possibly
occurred, or if it is discovered that you have a reportable communicable disease (certain sexually
transmitted diseases and/or HIV), then this information must be released to the appropriate
authorities or public health department. If you disclose illegal criminal activities, illegal
substance abuse, or violence, this information may be released to the appropriate authorities.
You also understand that your medical records could be examined by the sponsor, the
Institutional Review Board (a group of medical and lay people at this hospital charged with
protecting human subjects’ rights) or government agencies in order to verify the data collected
during this research study. If the results of this study are presented in any public forum, you will
not be identified by name.
Questions Regarding this Study
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If you have any questions about your rights as a subject in this clinical research study, you may
contact the IRB (Institutional Review Board) office at 248 849-8889 at Providence Hospital and
Medical Center.
If you have any questions regarding a research-related injury, you can contact: Dr. Howard
Schubiner at (248) 849-4728.
Authorization to Use and Disclose Protected Health Information (PHI)
Your participation in this study will require the use and disclosure of certain medical and other
information about you. You will not be able to participate if you do not agree to the use and
disclosure of your information.
The protected health information (PHI) that may be used or disclosed includes:
• All information collected during the research study as described in this form,
•

The information that is contained in any medical record that is created during your
participation in this research, and

• Other information in your medical record that may be considered related to your participation
in this research, which may include: your medical history, physical examination results,
laboratory test results or other test results (like an x-ray, scan, biopsy, EKG).
Who may see, use or disclose your PHI:
 The researchers and members of the research team
 Other health care providers or employees of St. John Health who provide services to you for
this study
 Representatives of the Institutional Review Board, the FDA (Food and Drug Administration),
or other governmental agencies involved in research monitoring
 Members of the safety monitoring board
 Other agencies as required by law
 The sponsor, ________________
 A clinical research organization, or other agent of the sponsor
 A laboratory outside of St. John Health System
What This Authorization Means
You understand that we cannot guarantee that your protected health information shared or
disclosed under this Authorization could not be additionally shared or disclosed by the individual
or organization that receives the information, and the privacy of your PHI may no longer be
protected by the law.
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You have the right to not agree to disclose your PHI. However, if you do not agree by signing
this Authorization, you will not be able to participate in this research study.
If you do sign below, you have the right to withdraw your permission at any time, but you must
do so in writing. You may send the written withdrawal to:
Dr. Howard Schubiner
Dept. of Internal Medicine
Providence Hospital and Medical Centers
16001 W. Nine Mile Rd.
Southfield, MI 48075
You may no longer be allowed to participate in the research if you withdraw your permission.
Also, you understand that any information collected before written notice of withdrawal is
received will be shared as you have agreed.
You have the right to review your PHI. However, if you agree to participate in the research
study and sign below, you will not be able to look at your research information until the research
study is completed.
You will receive a copy of this document, the Consent to Participate in a Clinical Research Study
and Authorization to Use or Disclose Protected Health Information for Research.
Expiration Date
Your authorization (permission) to use and disclose your health information will continue
indefinitely, subject to the procedures and limits described in this form. Your health information
will only be used for the purposes defined within this consent and authorization form.
Other Considerations
You have fully discussed and understand the purpose of this clinical research study and how it
will be carried out. You have been allowed to ask questions about the study and all of your
questions have been answered. You have read this consent form or had the complete form read
to you and understand it. You know that your participation in this study is fully voluntary and
you may withdraw at any time. If you refuse to participate or later withdraw from the study, it
will not affect your care in any way. You also understand that by consenting to participate in this
study, you are not waiving any other legal rights you may have because you are a subject in this
study or as a patient at Providence Hospital & Medical Center or at Wayne State University /
Detroit Medical Center.
Questions Regarding the Study
If you have any questions about your rights as a subject in this clinical research study, you may
contact the IRB (Institutional Review Board) office at (248) 849-8889 at Providence Hospital
and Medical Center. You may contact David Svinarich, Ph.D. of the Providence Hospital
Research Department at (248) 849-3326 for any questions about your rights as a research
participant. You may also contact the Chair of the Wayne State University Human Investigation
Committee at (313) 577-1628.
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You have the right to ask questions concerning this study at any time, and you are urged to do
so. If you have questions concerning the study or have a research related injury, you should
contact Dr. Howard Schubiner at (248) 849-4728 or Dr. Mark Lumley at (313) 577-2773.
Signatures
Research Subject
I voluntarily agree to participate in this research study. I understand the information printed on
this form. I have discussed this study, its risks and potential benefits, and my other choices with
____________________. My questions so far have been answered. I understand that if I have
more questions or concerns about the study or my participation as a research subject, I may
contact one of the people listed above. I understand that I will receive a copy of this form at the
time I sign it and later upon request. I understand that if my ability to consent for myself
changes, either I or my legal representative may be asked to re-consent prior to my continued
participation in this study.
Signature of Subject: _______________________________________________ Date:
___________
Name
(Print
legal
_____________________________________________________________

name):

Witness
I observed the above subject sign this consent document.
Signature of Witness: ______________________________________________
___________

Date:

Name:
____________________________________________________________________________

Principal Investigator
I have given this research subject (or his/her legally authorized representative, if applicable)
information about this study that I believe is accurate and complete. The subject has indicated
that he or she understands the nature of the study and the risks and benefits of participating.
Signature of Investigator: ___________________________________________ Date:
___________
Name: ___________________________________ Title:
___________________________________
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APPENDIX B (MEASURES)
BRIEF PAIN INVENTORY
1. Please rate your pain by circling the one number that best describes your pain at
its worst in the last week.
01
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as
you can imagine
2. Please rate your pain by circling the one number that best describes your pain at
its least in the last week.
01
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as
you can imagine
3. Please rate your pain by circling the one number that best describes your pain on
the average.
01
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as
you can imagine
4. Please rate your pain by circling the one number that tell how much pain you
have right now.
01
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as
you can imagine
For the next set of questions, choose the one number that describes how, during the
past week, pain has interfered with the following activities. Please use the 0 to 10
scale where a 0 means that “pain does not interfere with that activity” and a 10
means that “pain completely interferes.”
Does not
interfere
0

1

2

3

4

5

6

7

8

Completely
interferes
9
10

a) General Activity……………………………………………..…0 1 2 3 4 5 6 7
8 9 10
b) Mood……………………………………………………………....0 1 2 3 4 5 6
7 8 9 10
c) Mobility (ability to get around)……………….………….0 1 2 3 4 5 6 7 8 9
10
d) Normal Work (includes both work outside the home and housework)
.……………………………………………………………………….0 1 2 3 4 5 6
7 8 9 10
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e) Relations With Other People………………………..……0 1 2 3 4 5 6 7 8
9 10
f) Sleep………………………………………………………..………0 1 2 3 4 5 6
7 8 9 10
g) Enjoyment Of Life……………………………………..………0 1 2 3 4 5 6 7
8 9 10
h) Self Care (taking care of your daily needs)………...0 1 2 3 4 5 6 7 8 9
10
i) Recreational Activities……………………………………....0 1 2 3 4 5 6 7 8
9 10
j) Social Activities……………………………………………..….0 1 2 3 4 5 6 7
8 9 10
k) Communication With Others……………………..………0 1 2 3 4 5 6 7 8
9 10
l) Learning New Information or Skills…………………….0 1 2 3 4 5 6 7 8 9
10
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CENTER FOR EPIDEMIOLOGIC STUDIES—DEPRESSION SCALE
Circle the number of each statement which best describes how often you felt or
behaved this way – DURING THE PAST WEEK.
Rarely or Some or a Occasionally
Most or
none of
little of
or a moderate all of the
the time
the time
amount of the time (5-7
(less than (1-2 days)
time (3-4
days)
1 day)
days)
0
1
2
3
During the past week:
1) I was bothered by things
that usually don’t bother me

0

1

2

3

2) I did not feel like eating;
my appetite was poor

0

1

2

3

3) I felt that I could not
shake off the blues even
with help from my family
and friends

0

1

2

3

4) I felt that I was just as
good as other people

0

1

2

3

5) I had trouble keeping my
mind on what I was doing

0

1

2

3

6) I felt depressed

0

1

2

3

7) I felt that everything I did
was an effort

0

1

2

3

8) I felt hopeful about the
future

0

1

2

3

9) I thought my life had
been a failure

0

1

2

3

10) I felt fearful

0

1

2

3

11) My sleep was restless

0

1

2

3

12) I was happy

0

1

2

3

13) I talked less than usual

0

1

2

3

14) I felt lonely

0

1

2

3

15) People were unfriendly

0

1

2

3

16) I enjoyed life

0

1

2

3

17) I had crying spells

0

1

2

3

18) I felt sad

0

1

2

3

19) I felt that people
disliked me

0

1

2

3
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20) I could not get “going”

0

1

2

3

Satisfaction with Life Scale
Below are five statements that you may agree or disagree with. Using the 1 - 7 scale
below, indicate your agreement with each item by placing the appropriate number on
the line preceding that item. Please be open and honest in your responding.

•
•
•
•
•
•
•

7 - Strongly agree
6 - Agree
5 - Slightly agree
4 - Neither agree nor disagree
3 - Slightly disagree
2 - Disagree
1 - Strongly disagree

____ In most ways my life is close to my ideal.
____ The conditions of my life are excellent.
____ I am satisfied with my life.
____ So far I have gotten the important things I want in life.
____ If I could live my life over, I would change almost nothing.
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Chronic Pain Acceptance Questionnaire
Directions: below you will find a list of statements. Please rate the truth of each
statement as it applies to you. Use the following rating scale to make your choices.
For instance, if you believe a statement is `Always True,' you would write a 6 in the
blank next to that statement

1. I am getting on with the business of living no matter what my level of pain is .........
2. My life is going well, even though I have chronic pain .........
3. It's OK to experience pain .........
4. I would gladly sacrifice important things in my life to control this pain better .........
5. It's not necessary for me to control my pain in order to handle my life well .........
6. Although things have changed, I am living a normal life despite my chronic pain
.........
7. I need to concentrate on getting rid of my pain .........
8. There are many activities I do when I feel pain .........
9. I lead a full life even though I have chronic pain .........
10. Controlling pain is less important than any other goals in my life .........
11. My thoughts and feelings about pain must change before I can take important
steps in my life .........
12. Despite the pain, I am now sticking to a certain course in my life .........
13. Keeping my pain level under control takes first priority whenever I'm doing
something .........
14. Before I can make any serious plans, I have to get some control over my pain
.........
15. When my pain increases, I can still take care of my responsibilities .........
16. I will have better control over my life if I can control my negative thoughts about
pain .........
17. I avoid putting myself in situations where my pain might increase .........
18. My worries and fears about what pain will do to me are true .........
19. It's a relief to realize that I don't have to change my pain to get on with my life
.........
20. I have to struggle to do things when I have pain .........
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IMPACT OF EVENT SCALE-REVISED
Instructions: The following is a list of difficulties people sometimes have after stressful life events. Please read
each item, and then indicate how distressing each difficulty has been for you during the past 7 days with respect
to _______________, how much were you distressed or bothered by these difficulties?
Not
at all

A little
bit

Mode
rate-ly

Quite a
bit

1

Any reminder brought back feelings about it.

0

1

2

3

Extremely
4

2

I had trouble staying asleep.

0

1

2

3

4

3

Other things kept making me think about it.

0

1

2

3

4

4

I felt irritable and angry.

0

1

2

3

4

5

I avoided letting myself get upset when I thought about it or was
reminded of it.

0

1

2

3

4

6

I thought about it when I didn’t mean to.

0

1

2

3

4

7

I felt as if it hadn’t happened or wasn’t real.

0

1

2

3

4

8

I stayed away from reminders about it.

0

1

2

3

4

9

Pictures about it popped into my mind.

0

1

2

3

4

10

I was jumpy and easily startled.

0

1

2

3

4

11

I tried not to think about it.

0

1

2

3

4

12

I was aware that I still had a lot of feelings about it, but I didn’t deal with
them.

0

1

2

3

4

13

My feelings about it were kind of numb.

0

1

2

3

4

14

I found myself acting or feeling like I was back at that time.

0

1

2

3

4

15

I had trouble falling asleep.

0

1

2

3

4

16

I had waves of strong feelings about it.

0

1

2

3

4

17

I tried to remove it from my memory.

0

1

2

3

4

18

I had trouble concentrating.

0

1

2

3

4

19

Reminders of it caused me to have physical reactions, such as sweating,
trouble breathing, nausea, or a pounding heart.

0

1

2

3

4

20

I had dreams about it.

0

1

2

3

4

21

I felt watchful and on guard.

0

1

2

3

4

22

I tried not to talk about it.

0

1

2

3

4
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TAS-20

Please indicate how much you agree or disagree with each of the following statements
by writing a number from 1 to 5 in the blank in front of the statement. Use this scale:
1 = Strongly disagree
2 = Disagree
3 = Neither disagree nor agree
4 = Agree
5 = Strongly agree
1.

I am often confused about what emotion I am feeling.

2.

It is difficult for me to find the right words for my feelings.

3.

I have physical sensations that even doctors don’t understand.

4.

I am able to describe my feelings easily.

5.

I prefer to analyze problems rather than just describe them.

6.

When I am upset, I don’t know if I am sad, frightened or angry.

7.

I am often puzzled by sensations in my body.

8.

I prefer to just let things happen rather than to understand why they turned out that way.

9.

I have feelings that I cant quite identify.

10.

Being in touch with emotions is essential.

11.

I find it hard to describe how I feel.

12.

People tell me to describe my feelings more.

13.

I don’t know what’s going on inside me.

14.

I often don’t know why I am angry.

15.

I prefer talking to people about their daily activities rather than their feelings.

16.

I prefer to watch “light” entertainment shows rather than psychological dramas.

17.

It is difficult for me to reveal my innermost feelings, even to close friends.

18.

I can feel close to someone, even in moments of silence.

19.

I find examination of my feelings useful in solving personal problems.

20.

Looking for hidden meaning in movies or plays distracts from their enjoyment.
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Code ___
AEQ

Below are some statements that refer to how people sometimes feel and act. Using the
following scale, rate each statement to indicate how frequently you have felt or
experience each one.
1
I have never
felt like this

2

3

4

5
I feel like
this a lot

The statements may consist of 2 thoughts. Carefully read the statement as a whole before deciding on
how characteristic it is of you. For example, consider item:
“ I try to honestly criticize others for their own good, but I worry they may get angry with me if I do so”
You would give this time a high rating if and only If both parts of the statement apply to you; that is, you
try to honestly criticize others and you worry about their getting angry. If only one part of the statement
applies to you, you would give this item a lower rating. It is important to consider the complete thoughts
being expressed before you respond.
___1. I make an effort to control my temper at all times even though I’d like to act on these feelings at
times.
___ 2. Often I’d like to show others how I feel, but something seems to hold me back.
___3. I try to refrain from getting angry at my family even though I want to at times.
___ 4. I try to show people that I love them, although at times I am afraid that it may make me appear
weak or too sensitive.
___ 5. Often I find that I am not able to tell others how much they really mean to me.
___ 6. I want to tell someone when I love them, but it is difficult to find the right words.
___ 7. I would like to express my disappointment when things don’t go as well as planned, but I don’t
want to appear vulnerable.
___ 8. I would like to be more spontaneous in my emotional reactions, but I just can’t seem to do it
___ 9. I try to suppress my anger, but I would like other people to know how I feel.
___ 10. It is hard to find the right words to indicate to others what I am really feelings.
___ 11. I worry that if I express negative emotions such as fear and anger, other people will not approve
of me.
___ 12. I feel guilty after I have expressed my anger to someone.
___ 13. I often cannot bring myself to express what I am really feeling.
___ 14. After I express anger at someone, it bothers me for a long time.
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Communicating Thoughts and Feelings Questionnaire
(Mark A. Lumley & Amanda Burger, Wayne State University)

In this questionnaire, you will be presented with a series of situations that could happen
between you and another person, and a response that you might make to that person. You
should read the situation and the response, and then think about how likely you are to make that
response.
For each scenario, you should think about making the response to each of four different
people—your father (or the primary male authority during your first 18 years), your mother, your
significant other, and a stranger (someone with whom you have no relationship).
A significant other is the person with whom you feel closest, typically a spouse or partner. If you
do not have a spouse or partner, then you should select anyone that you relate to on a regular
basis. Please indicate who your significant other is (check one):

__Spouse

__Partner/Companion

___Housemate/Roommate

__ Friend

___Child or other relative

__ Neighbor
__Other (describe):________

For each of the four relationships, enter a number from 0 to 4 regarding how likely you are to
make that response to that person.
0 = Definitely can not do it
1 = Probably can not do it
2 = Can probably do it, but with some difficulty
3 = Can do it with only a little difficulty
4 = Can do it easily
1. You have done something wrong to the person. Can you tell that person that you are sorry
for doing it to them?
____
____
____
____

Father
Mother
Significant other
Stranger

2. You are asked to do something for the person, but you do not want to. Can you tell that
person that you do not want to do it?
____
____
____
____

Father
Mother
Significant other
Stranger
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3. The person has helped you. Can you tell that person that you are thankful for what they have
done?
____
____
____
____

Father
Mother
Significant other
Stranger

4. The person has done something to you that makes you mad. Can you tell that person that
you are mad because of what they did?
____
____
____
____

Father
Mother
Significant other
Stranger

5. The person has achieved something or has positive qualities. Can you compliment or praise
that person?
____
____
____
____

Father
Mother
Significant other
Stranger

6. You want the person to do something for you. Can you directly tell that person to do it?
____
____
____
____

Father
Mother
Significant other
Stranger

7. Somebody has hurt you in the past and seeks your forgiveness. Can you tell them that you
forgive them?
____
____
____
____

Father
Mother
Significant other
Stranger

8. You disagree with the person’s opinion about a topic that is important to you, and believe that
they are wrong. Can you tell that person that you disagree with them and that they are wrong?
____ Father
____ Mother
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____ Significant other
____ Stranger

9. You feel love toward the person. Can you tell that person “I love you.”?
____
____
____
____

Father
Mother
Significant other
Stranger

11. You want to make a connection with the person. Can you give that person an embrace or
hug?
____
____
____
____

Father
Mother
Significant other
Stranger

13. You have done something that you feel guilty or ashamed about. Can you tell or share with
the person what you have done?
____
____
____
____

Father
Mother
Significant other
Stranger
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Date ________________
Treatment Attitudes Survey: Pre-Treatment
1. What do you think causes your pain? (Ex. stress, diet, genetics, injury, etc.). Please describe as
fully as possible.
________________________________________________________________________________
________________________________________________________________________________
2. How much do you think that biological, medical, or genetic factors cause your pain?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

3. How much do you think that psychological factors such as stress or emotions cause your pain?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

4. How much do you think that stressful life events or emotional trauma caused your pain problem?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

5. How much to you think that stressful life events or emotional trauma make your pain worse?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

6. How much do you think that the source or cause of your pain is in your mind?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

3
Quite a lot

4
Completely

7. How much do you think that your mind can eliminate the pain?
0
Not at all

1
A little bit

2
Moderately

8. How much do you agree with the suggestion that a medical disease is NOT the source of your
pain?
0
1
2
3
4
Not at all
A little bit
Moderately
Quite a lot
Completely
9. How much of Dr. Sarno’s book, The Mindbody Prescription, did you read?
0
Not at all

1
A little bit

2
Moderately

3
Quite a lot

4
Completely

3
Quite a lot

4
Completel

10. How much did your pain improve after reading the book?
0
Not at all

1
A little bit

2
Moderately
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APPENDIX C (Emotional Assessment)

Communicating Feelings Therapeutic Assessment Exercise
(Assessor Script and Rating Scale)
(Mark A. Lumley & Amanda Burger, Wayne State University)

“People have important thoughts and feelings about things that happen in relationships. Some
thoughts and feelings can be expressed easily comfortably, but other feelings are hard to
express or communicate.
In this exercise, I am going to ask you to demonstrate how you might communicate 7 different
feelings. For each one, I’ll describe a situation, and ask you to demonstrate how you might
communicate it, using both words as well as nonverbal expressions, such as with your tone of
voice, your eyes, your hands, and your posture. I’ll give you more explanations as we go along.
(For each task, read the italicized text. Each section has a default phrase for participants who
struggle with the task. Rate the patient’s performance on each task using the 0-4 rating scale
below.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

1. Declining a request
Imagine that you have been asked to do something for someone, but you do not want to
it. How would you express that you do not want to do it?

a) Generic demonstration (without any specific target or example)
First, I would like you to demonstrate how you might decline a request in general; that is, without
thinking of any specific person or example in your life. I want to see what it is like for you to
communicate with your words and actions, so I would like you to demonstrate how you might
decline a request in the most direct, genuine, and straightforward way possible, using your tone
of voice, emotions, mannerisms, and actions.

(If participant struggles have them use the phrase: “No I do not want to do that.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
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___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

b) Specific target and example
Now I would like to repeat this exercise, but this time, have you demonstrate it with respect to
someone in your life who you need to decline a request from. Ideally, it should be someone in
your life right now, about a situation with that person that you would like to decline, but it could
be a person and situation from your past. Take a few moments and think about that person and
the situation, and what you are going to say to them. (Pause). Now imagine that the person is
sitting in that chair. You should tell them directly and honestly your feelings and wishes. You
should use their first name and be specific about what the request is that you are declining. You
should use any words, tone, actions, or mannerisms to help get your message across genuinely
and directly.
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ not able to think of an example

2. Expressing gratitude
Imagine that somebody has done something helpful to you. How would you express your
thankfulness or gratitude to that person for what they have done?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate how you might express to someone that you are thankful
for something they have done, but without thinking of any specific person or example in your
life. I want to see what it is like for you to communicate with your words and actions. Please do
so in a direct, genuine, and straightforward way using your tone of voice, emotions,
mannerisms, and actions.

(If participant struggles have them use the phrase: “Thank you for helping me.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase
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b) Do it specifically to a difficult target and with specific example
Now take a few minutes to think about someone in your life who you need to express that you
are thankful to them because of something they have done for you. Ideally, it should be
someone in the present to whom it is difficult to express thanks to. Take a couple of minutes
and think about that person and situation, and how you are going to express it to them. Now
imagine that the person is sitting in that chair. You should tell them directly, honestly your
feelings and wishes. You should use their first name and be specific about what you are
thankful for. You should use any actions or mannerisms that help get your message across
genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to communicate anger and use the phrase “Thank you for helping me.” and
still imagine they are speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

3. Making a demand
Imagine that you need help and believe that somebody should help you. How would you
express to that person that you expect them to help you?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate making a demand of someone without thinking of any
specific person or example in your life. I want to see what it is like for you to express this with
your words and actions. Please do so in a direct, genuine, and straightforward way using your
tone of voice, emotions, mannerisms, and actions.

(If participant struggles have them use the phrase: “I need you to help me.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase
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b) Do it specifically to a difficult target and with specific example
Now take a few minutes to think about someone in your life who you think you should help you
do something. Ideally, it should be someone in the present who it is difficult to make a demand
to. Take a couple of minutes and think about that person and situation, and what you are going
to say to them. Now imagine that the person is sitting in that chair. You should tell them directly,
honestly your feelings and wishes. You should use their first name and be specific about what
help you need. You should use any actions or mannerisms that help get your message across
genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to make a demand and use the phrase “I need you to help me.” and still
imagine they are speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

4. Expressing love
Imagine that you are close to a person and love them. How would you express to that
person that you love them?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate telling somebody that you love them without thinking of
any specific person or example in your life. I want to see what it is like for you to communicate
this with your words and actions. Please do so in a direct, genuine, and straightforward way
using your tone of voice, emotions, mannerisms, and actions.

(If participant struggles have them use the phrase: “I love you.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

b) Do it specifically to a difficult target and with specific example
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Now take a few minutes to think about someone in your life who you need to express to them
that you love them. Ideally, it should be someone in the present who it is difficult to express
love to. Take a couple of minutes and think about that person and situation, and what you are
going to say to them. Now imagine that the person is sitting in that chair. You should tell them
directly, honestly your feelings and wishes. You should use their first name and be specific
about what help you need. You should use any actions or mannerisms that help get your
message across genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to communicate love and use the phrase “I love you.” and still imagine they are
speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

5. Disagreeing and stating that a person is wrong about an important topic
Imagine that you disagree with someone and believe that they are wrong about some topic.
How would you tell that person that you think they are wrong?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate expressing to somebody that you disagree with them and
that they are wrong about an important topic, but do this without thinking of any specific person
or example in your life. I want to see what it is like for you to communicate that with your words
and actions. Please do so in a direct, genuine, and straightforward way using your tone of
voice, emotions, mannerisms, and actions.

(If participant struggles have them use the phrase: “I think that you are wrong and I disagree
with you.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase
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b) Do it specifically to a difficult target and with specific example
Now take a few minutes to think about someone in your life who you need to express that you
disagree with them, and that they are wrong. Ideally, it should be someone in the present who it
is difficult to disagree with. Take a couple of minutes and think about that person and situation,
and what you are going to say to them. Now imagine that the person is sitting in that chair. You
should tell them directly, honestly your feelings and wishes. You should use their name and be
specific about what you disagree about and how wrong they are. You should use any actions or
mannerisms that help get your message across genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to communicate anger and use the phrase “I think that you are wrong and I
disagree with you” and still imagine they are speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

6. Apologizing
Imagine that you have done something wrong to another person. How would you
express to that person that you are sorry for doing it to them?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate expressing to somebody that you are sorry for something
you have done, without thinking of any specific person or example in your life. I want to see
what it is like for you to communicate with your words and actions the following idea. Please do
so in a direct, genuine, and straightforward way using your tone of voice, emotions,
mannerisms, and actions.

(If participant struggles have them use the phrase: “I am sorry that I hurt your feelings.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

b) Do it specifically to a difficult target and with specific example
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Now take a few minutes to think about someone in your life to whom you need to express that
you are sorry for something you have done. Ideally, it should be someone in the present who it
is difficult to apologize to. Take a couple of minutes and think about that person and situation,
and what you are going to say to them. Now imagine that the person is sitting in that chair. You
should tell them directly, honestly your feelings and wishes. You should use their first name and
be specific about what you are sorry for. You should use any actions or mannerisms that help
get your message across genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to apologize to and use the phrase “I am sorry that I hurt your feelings.” and
still imagine they are speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase

7. Communicating anger
Imagine that somebody has made you mad. How would you tell that person that you are
angry with them?
a) Do it generically (without any specific target or example)
First, I would like you to demonstrate how you would express that you are mad because of
something they have done, without thinking of any specific person or example in your life. I
want to see what it is like for you to communicate with your words and actions the following
idea. Please do so in a direct, genuine, and straightforward way using your tone of voice,
emotions, mannerisms, and actions.

(If participant struggles have them use the phrase: “I am angry with you.”)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase
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b) Do it specifically to a difficult target and with specific example
Now take a few minutes to think about someone in your life to whom you need to express that
you are angry with them because of something they have done. Ideally, it should be someone
in the present who it is difficult to show anger to. Take a couple of minutes and think about that
person and situation, and what you are going to say to them. Now imagine that the person is
sitting in that chair. You should tell them directly, honestly your feelings and wishes. You should
use their first name and be specific about what made you mad. You should use any actions or
mannerisms that help get your message across genuinely and directly.
(If the participant cannot think of their own example have them identify a person with whom it
would be difficult to communicate anger and use the phrase “I am angry with you.” and still
imagine they are speaking to that person.)
___ 0 = Did not do it at all
___ 1 = Did it with great difficulty
___ 2 = Did it with some difficulty
___ 3 = Did it with a little difficulty
___ 4 = Did it easily
___ used the default phrase
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APPENDIX D (Exploration Questions)

Exploration Questions
1. Were there any parts of these tasks that were particularly difficult for you?
2. Were there any parts of these tasks that were particularly easy for you?
3. How typical were these responses to your everyday communication with people
in your life?
4. How does the way you handle your emotions and needs affect your pain and
your relationships?
5. Is there anything you would like to change about how you express your emotions
and needs?
6. What kind of treatment goals can you make based on what you have learned
today?
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Chronic pain is a leading cause of suffering, disability, and high health care
costs. Traditional treatment approaches such as medical or cognitive-behavioral
interventions have produced variable and often limited results. Research has suggested
that increased rates of stressful life events, emotional disorders, and emotion regulation
deficits contribute to the development and maintenance of chronic pain problems that
lack clear, peripheral, biological causes. This study examined the effectiveness of an
innovative, emotion-focused treatment that directly targets patients’ unresolved stress
and emotional avoidance and sought to identify predictors of treatment outcome.
Additionally, this study explored the effects of a novel, emotional assessment on
treatment outcome by randomizing half of the participants to complete this assessment
prior to treatment.
To be included in the study, patients reported chronic pain for at least 3 months
duration that had substantial psychological factors that contributed to the pain. Forty-six
patients participated (76% women and 91% Caucasian). Pain, pain-related disability,
depression, general emotional distress, and satisfaction with life were assessed at
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baseline, post-treatment, and a 3-month follow-up. Stressful life events and emotion
regulation ability were also assessed at baseline. The 4-session group treatment uses
readings, writing about emotions, meditation, and other techniques to help people
identify, understand, and verbalize emotions related to stressful life events or emotional
conflict.
Results indicated significant improvements for pain, pain-related disability and
acceptance, depression, general emotional distress, and satisfaction with life. Effect
sizes were generally medium or large and reliable change analyses indicated that
approximately half of the patients showed at least a moderate effect across all the
outcome domains. Increased levels of baseline depression and stress generally
predicted improved treatment outcomes, whereas poorer baseline emotion regulation
predicted inconsistent results. The baseline emotional assessment had no significant
effect on the outcome measures. This study suggests that this emotion-focused
treatment led to substantial improvements in pain, pain-related functioning, and
emotional symptoms. Further research should seek to clarify the predictors of treatment
outcome and the process by which it works.
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